```

[Congressional Bills 114th Congress]
[From the U.S. Government Publishing Office]
[S. 524 Reported in Senate (RS)]

<DOC>

                                                       Calendar No. 369
114th CONGRESS
  2d Session
                                 S. 524

   To authorize the Attorney General to award grants to address the 
    national epidemics of prescription opioid abuse and heroin use.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                           February 12, 2015

 Mr. Whitehouse (for himself, Mr. Portman, Ms. Klobuchar, Ms. Ayotte, 
    Mr. Coons, Mr. Kirk, Mr. Nelson, Ms. Warren, Mr. Franken, Mrs. 
 Feinstein, Mr. Schumer, Mrs. Gillibrand, Ms. Collins, Mr. Hatch, Mr. 
Graham, Ms. Baldwin, Mr. Menendez, Mrs. Shaheen, Mr. King, Mr. Manchin, 
Mr. Blumenthal, Mr. Leahy, Mrs. Capito, Mr. Donnelly, Mr. Sullivan, Mr. 
 Heinrich, Mr. Tester, Mr. Rubio, Mr. Udall, Mr. Durbin, Mr. Grassley, 
  Mr. Cornyn, and Mr. Blunt) introduced the following bill; which was 
       read twice and referred to the Committee on the Judiciary

                           February 22, 2016

              Reported by Mr. Grassley, with an amendment
 [Strike out all after the enacting clause and insert the part printed 
                               in italic]

_______________________________________________________________________

                                 A BILL

 
   To authorize the Attorney General to award grants to address the 
    national epidemics of prescription opioid abuse and heroin use.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

<DELETED>SECTION 1. SHORT TITLE; TABLE OF CONTENTS.</DELETED>

<DELETED>    (a) Short Title.--This Act may be cited as the 
``Comprehensive Addiction and Recovery Act of 2015''.</DELETED>
<DELETED>    (b) Table of Contents.--The table of contents for this Act 
is as follows:</DELETED>

<DELETED>Sec. 1. Short title; table of contents.
<DELETED>Sec. 2. Findings.
<DELETED>Sec. 3. Definitions.
               <DELETED>TITLE I--PREVENTION AND EDUCATION

<DELETED>Sec. 101. Development of best prescribing practices.
<DELETED>Sec. 102. National education campaign.
<DELETED>Sec. 103. Community-based coalition enhancement grants to 
                            address local drug crises.
            <DELETED>TITLE II--LAW ENFORCEMENT AND TREATMENT

<DELETED>Sec. 201. Treatment alternative to incarceration programs.
<DELETED>Sec. 202. Law enforcement naloxone training and implementation 
                            demonstration.
<DELETED>Sec. 203. Prescription drug take back expansion.
               <DELETED>TITLE III--TREATMENT AND RECOVERY

<DELETED>Sec. 301. Evidence-based opioid and heroin treatment and 
                            interventions demonstration.
<DELETED>Sec. 302. Criminal justice medication assisted treatment and 
                            interventions demonstration.
<DELETED>Sec. 303. National youth recovery initiative.
<DELETED>Sec. 304. Building communities of recovery.
         <DELETED>TITLE IV--ADDRESSING COLLATERAL CONSEQUENCES

<DELETED>Sec. 401. Correctional education demonstration grant program.
<DELETED>Sec. 402. Revision of FAFSA form.
<DELETED>Sec. 403. National Task Force on Recovery and Collateral 
                            Consequences.
<DELETED>TITLE V--ADDICTION AND TREATMENT SERVICES FOR WOMEN, FAMILIES, 
                              AND VETERANS

<DELETED>Sec. 501. Authority to award competitive grants to address 
                            opioid and heroin abuse by pregnant and 
                            parenting female offenders.
<DELETED>Sec. 502. Grants for family-based substance abuse treatment.
<DELETED>Sec. 503. Veterans' treatment courts.
  <DELETED>TITLE VI--INCENTIVIZING STATE COMPREHENSIVE INITIATIVES TO 
                    ADDRESS OPIOID AND HEROIN ABUSE

<DELETED>Sec. 601. State demonstration grants for comprehensive opioid 
                            abuse response.
                 <DELETED>TITLE VII--OFFSET; GAO REPORT

<DELETED>Sec. 701. Offset.
<DELETED>Sec. 702. GAO report on IMD exclusion.

<DELETED>SEC. 2. FINDINGS.</DELETED>

<DELETED>    Congress finds the following:</DELETED>
        <DELETED>    (1) The abuse of heroin and prescription 
        painkillers is having a devastating effect on public health and 
        safety in communities across the United States. According to 
        the Centers for Disease Control and Prevention, drug overdose 
        deaths now surpass traffic crashes in the number of deaths 
        caused by injury in the United States. In 2011, an average of 
        about 110 people in the United States died from drug overdose 
        every day.</DELETED>
        <DELETED>    (2) Law enforcement officials and treatment 
        experts throughout the country report that many prescription 
        opioid users have turned to heroin as a cheaper or more easily 
        obtained alternative to prescription drugs.</DELETED>
        <DELETED>    (3) Opioid pain relievers are the most widely 
        misused or abused controlled prescription drugs (commonly 
        referred to as ``CPDs'') and are involved in most CPD-related 
        overdose incidents. According to the Drug Abuse Warning Network 
        (commonly known as ``DAWN''), the estimated number of emergency 
        department visits involving nonmedical use of prescription 
        opiates or opioids increased by 112 percent between 2006 and 
        2010, from 84,671 to 179,787.</DELETED>
        <DELETED>    (4) According to a report by the National 
        Association of State Alcohol and Drug Abuse Directors (commonly 
        referred to as ``NASADAD''), 37 States reported an increase in 
        admissions to treatment for heroin use during the past 2 years, 
        while admissions to treatment for prescription opiates 
        increased 500 percent from 2000 to 2012.</DELETED>
        <DELETED>    (5) Substance use disorders are a treatable 
        disease. Discoveries in the science of addiction have led to 
        advances in the treatment of substance use disorders that help 
        people stop abusing drugs and prescription medications and 
        resume their productive lives.</DELETED>
        <DELETED>    (6) According to the National Survey on Drug Use 
        and Health, approximately 22,700,000 people in the United 
        States needed substance use disorder treatment in 2013, but 
        only 2,500,000 people received it. Furthermore, current 
        treatment services are not adequate to meet demand. According 
        to a report commissioned by SAMHSA, there are approximately 32 
        providers for every 1,000 individuals needing substance use 
        disorder treatment. In some States, the ratio is much 
        lower.</DELETED>
        <DELETED>    (7) Effective substance abuse prevention can yield 
        major economic dividends.</DELETED>
        <DELETED>    (8) According to the National Institute on Drug 
        Abuse, when schools and communities properly implement science-
        validated substance abuse prevention programs, abuse of 
        alcohol, tobacco, and illicit drugs is reduced. Such programs 
        help teachers, parents, and healthcare professionals shape the 
        perceptions of youths about the risks of drug abuse.</DELETED>
        <DELETED>    (9) Diverting individuals with substance use 
        disorders from criminal justice systems into community-based 
        treatment can save billions of dollars and prevent sizeable 
        numbers of crimes, arrests, and re-incarcerations over the 
        course of those individuals' lives.</DELETED>
        <DELETED>    (10) According to the Drug Enforcement Agency, 
        more than 1,700 tons of expired, unwanted prescription 
        medications have been collected during the past 3\1/2\ years, 
        following the enactment of the Secure and Responsible Drug 
        Disposal Act of 2010 (Public Law 111-273; 124 Stat. 
        2858).</DELETED>
        <DELETED>    (11) Research shows that combining treatment 
        medications with behavioral therapy is the best way to 
        facilitate success for most patients. Treatment approaches must 
        be tailored to address the drug abuse patterns and drug-related 
        medical, psychiatric, and social problems of each individual. 
        Different types of medications may be useful at different 
        stages of treatment or recovery to help a patient stop using 
        drugs, stay in treatment, and avoid relapse.</DELETED>
        <DELETED>    (12) Research indicates that combating the opioid 
        crisis, including abuse of prescription painkillers and, 
        increasingly, heroin, requires a multi-pronged approach that 
        involves reducing drug diversion, expanding delivery of 
        existing treatments (including medication assisted treatments), 
        expanding access to overdose medications and interventions, and 
        the development of new medications for pain that can augment 
        the existing treatment arsenal.</DELETED>
        <DELETED>    (13) Individuals with mental illness, especially 
        severe mental illness, are at considerably higher risk for 
        substance abuse than the general population, and the presence 
        of a mental illness complicates recovery from substance 
        abuse.</DELETED>

<DELETED>SEC. 3. DEFINITIONS.</DELETED>

<DELETED>    In this Act--</DELETED>
        <DELETED>    (1) the term ``medication assisted treatment'' 
        means the use, for problems relating to heroin and other 
        opioids, of medications approved by the Food and Drug 
        Administration in combination with counseling and behavioral 
        therapies;</DELETED>
        <DELETED>    (2) the term ``ONDCP Recovery Branch'' means the 
        Recovery Branch of the Office of National Drug Control 
        Policy;</DELETED>
        <DELETED>    (3) the term ``opioid'' means any drug having an 
        addiction-forming or addiction-sustaining liability similar to 
        morphine or being capable of conversion into a drug having such 
        addiction-forming or addiction-sustaining liability; 
        and</DELETED>
        <DELETED>    (4) the term ``State'' means any State of the 
        United States, the District of Columbia, the Commonwealth of 
        Puerto Rico, and any territory or possession of the United 
        States.</DELETED>

          <DELETED>TITLE I--PREVENTION AND EDUCATION</DELETED>

<DELETED>SEC. 101. DEVELOPMENT OF BEST PRESCRIBING PRACTICES.</DELETED>

<DELETED>    (a) Inter-Agency Task Force.--Not later than 120 days 
after the date of enactment of this Act, the Secretary of Health and 
Human Services (referred to in this section as the ``Secretary''), in 
cooperation with the Secretary of Veterans Affairs, the Secretary of 
Defense, and the Administrator of the Drug Enforcement Administration, 
shall convene a Pain Management Best Practices Inter-Agency Task Force 
(referred to in this section as the ``task force'').</DELETED>
<DELETED>    (b) Membership.--The task force shall be comprised of--
</DELETED>
        <DELETED>    (1) representatives of--</DELETED>
                <DELETED>    (A) the Department of Health and Human 
                Services;</DELETED>
                <DELETED>    (B) the Department of Veterans 
                Affairs;</DELETED>
                <DELETED>    (C) the Department of Defense;</DELETED>
                <DELETED>    (D) the Drug Enforcement 
                Administration;</DELETED>
                <DELETED>    (E) the Centers for Disease Control and 
                Prevention;</DELETED>
                <DELETED>    (F) the Institute of Medicine; 
                and</DELETED>
                <DELETED>    (G) the Office of National Drug Control 
                Policy;</DELETED>
        <DELETED>    (2) the Director of the National Institutes of 
        Health;</DELETED>
        <DELETED>    (3) physicians, dentists, and non-physician 
        prescribers;</DELETED>
        <DELETED>    (4) pharmacists;</DELETED>
        <DELETED>    (5) experts in the fields of pain research and 
        addiction research;</DELETED>
        <DELETED>    (6) representatives of--</DELETED>
                <DELETED>    (A) pain management professional 
                organizations;</DELETED>
                <DELETED>    (B) the mental health treatment 
                community;</DELETED>
                <DELETED>    (C) the addiction treatment 
                community;</DELETED>
                <DELETED>    (D) pain advocacy groups; and</DELETED>
                <DELETED>    (E) groups with expertise around overdose 
                reversal; and</DELETED>
        <DELETED>    (7) other stakeholders, as the Secretary 
        determines appropriate.</DELETED>
<DELETED>    (c) Duties.--The task force shall--</DELETED>
        <DELETED>    (1) not later than 180 days after the date on 
        which the task force is convened under subsection (a), develop 
        best practices for pain management (including chronic and acute 
        pain) and prescribing pain medication, taking into 
        consideration--</DELETED>
                <DELETED>    (A) existing pain management 
                research;</DELETED>
                <DELETED>    (B) recommendations from relevant 
                conferences;</DELETED>
                <DELETED>    (C) ongoing efforts at the State and local 
                levels and by medical professional organizations to 
                develop improved pain management strategies; 
                and</DELETED>
                <DELETED>    (D) the management of high-risk 
                populations, other than populations who suffer pain, 
                who--</DELETED>
                        <DELETED>    (i) may use or be prescribed 
                        benzodiazepines, alcohol, and diverted opioids; 
                        or</DELETED>
                        <DELETED>    (ii) receive opioids in the course 
                        of medical care;</DELETED>
        <DELETED>    (2) solicit and take into consideration public 
        comment on the practices developed under paragraph (1), 
        amending such best practices if appropriate; and</DELETED>
        <DELETED>    (3) develop a strategy for disseminating 
        information about the best practices developed under paragraphs 
        (1) and (2) to prescribers, health professionals, pharmacists, 
        State medical boards, and other parties, as the Secretary 
        determines appropriate.</DELETED>
<DELETED>    (d) Limitation.--The task force shall not have rulemaking 
authority.</DELETED>
<DELETED>    (e) Report.--Not later than 270 days after the date on 
which the task force is convened under subsection (a), the task force 
shall submit to Congress a report that includes--</DELETED>
        <DELETED>    (1) the strategy for disseminating best practices 
        developed under subsection (c);</DELETED>
        <DELETED>    (2) the results of a feasibility study on linking 
        best practices developed under subsection (c) to receiving and 
        renewing registrations under section 303(f) of the Controlled 
        Substances Act (21 U.S.C. 823(f)); and</DELETED>
        <DELETED>    (3) recommendations on how to apply best practices 
        developed under subsection (c) to improve prescribing practices 
        at medical facilities, including medical facilities of the 
        Veterans Health Administration.</DELETED>

<DELETED>SEC. 102. NATIONAL EDUCATION CAMPAIGN.</DELETED>

<DELETED>    Title I of the Omnibus Crime Control and Safe Streets Act 
of 1968 (42 U.S.C. 3711 et seq.) is amended by adding at the end the 
following:</DELETED>

          <DELETED>``PART MM--DRUG TREATMENT GRANTS</DELETED>

<DELETED>``SEC. 3031. DEFINITIONS.</DELETED>

<DELETED>    ``In this part--</DELETED>
        <DELETED>    ``(1) the term `civil liability protection law' 
        means a State law that protects from civil liability 
        individuals who give aid on a voluntary basis in an emergency 
        to individuals who are ill, in peril, or otherwise 
        incapacitated;</DELETED>
        <DELETED>    ``(2) the term `medication assisted treatment' 
        means the use, for problems relating to heroin and other 
        opioids, of medications approved by the Food and Drug 
        Administration in combination with counseling and behavioral 
        therapies;</DELETED>
        <DELETED>    ``(3) the term `opioid' means any drug having an 
        addiction-forming or addiction-sustaining liability similar to 
        morphine or being capable of conversion into a drug having such 
        addiction-forming or addiction-sustaining liability; 
        and</DELETED>
        <DELETED>    ``(4) the term `Single State Authority for 
        Substance Abuse' has the meaning given the term in section 
        201(e) of the Second Chance Act of 2007 (42 U.S.C. 
        17521(e)).</DELETED>

<DELETED>``SEC. 3032. NATIONAL EDUCATION CAMPAIGN.</DELETED>

<DELETED>    ``(a) Definitions.--In this section--</DELETED>
        <DELETED>    ``(1) the term `eligible entity' means a State, 
        unit of local government, or nonprofit organization; 
        and</DELETED>
        <DELETED>    ``(2) the terms `elementary school' and `secondary 
        school' have the meaning given those terms in section 9101 of 
        the Elementary and Secondary Education Act of 1965 (20 U.S.C. 
        7801).</DELETED>
<DELETED>    ``(b) Program Authorized.--The Attorney General, in 
coordination with the Secretary of Health and Human Services, the 
Director of the Office of National Drug Control Policy, the Secretary 
of Education, the Administrator of the Substance Abuse and Mental 
Health Services Administration, and the Director of the Centers for 
Disease Control and Prevention, may make grants to eligible entities to 
expand educational efforts to prevent abuse of opioids, heroin, and 
other substances of abuse, understand addiction as a chronic disease, 
and promote treatment and recovery, including--</DELETED>
        <DELETED>    ``(1) parent and caretaker-focused prevention 
        efforts, including--</DELETED>
                <DELETED>    ``(A) the development of research-based 
                community education online and social media materials 
                with an accompanying toolkit that can be disseminated 
                to communities to educate parents and other caretakers 
                of teens on--</DELETED>
                        <DELETED>    ``(i) how to educate teens about 
                        opioid and heroin abuse;</DELETED>
                        <DELETED>    ``(ii) how to intervene if a 
                        parent thinks or knows their teen is abusing 
                        opioids or heroin;</DELETED>
                        <DELETED>    ``(iii) signs of opioid or heroin 
                        overdose; and</DELETED>
                        <DELETED>    ``(iv) the use of naloxone to 
                        prevent death from opioid or heroin 
                        overdose;</DELETED>
                <DELETED>    ``(B) the development of detailed digital 
                and print educational materials to accompany the online 
                and social media materials and toolkit described in 
                subparagraph (A);</DELETED>
                <DELETED>    ``(C) the development and dissemination of 
                public service announcements to--</DELETED>
                        <DELETED>    ``(i) raise awareness of heroin 
                        and opioid abuse among parents and other 
                        caretakers;</DELETED>
                        <DELETED>    ``(ii) motivate parents and other 
                        caretakers to visit online educational 
                        materials on heroin and opioid abuse; 
                        and</DELETED>
                        <DELETED>    ``(iii) provide information for 
                        public health agencies and nonprofit 
                        organizations that provide overdose reversal 
                        and prevention services and community 
                        referrals; and</DELETED>
                <DELETED>    ``(D) the dissemination of educational 
                materials to the media through--</DELETED>
                        <DELETED>    ``(i) a town hall or panel 
                        discussion with experts;</DELETED>
                        <DELETED>    ``(ii) a press release;</DELETED>
                        <DELETED>    ``(iii) an online news 
                        release;</DELETED>
                        <DELETED>    ``(iv) a media tour; and</DELETED>
                        <DELETED>    ``(v) sharable 
                        infographics;</DELETED>
        <DELETED>    ``(2) prevention efforts focused on teenagers, 
        young adults, and college students, including the development 
        of--</DELETED>
                <DELETED>    ``(A) a national digital 
                campaign;</DELETED>
                <DELETED>    ``(B) a community education toolkit for 
                use by community coalitions;</DELETED>
                <DELETED>    ``(C) evidence-based resources for 
                prevention and treatment professionals targeting 
                individuals who are between 18 and 24 years of age, 
                including college students; and</DELETED>
                <DELETED>    ``(D) technical support centers for 
                prevention and treatment professionals, elementary and 
                secondary school-based professionals, and college-based 
                professionals, including recovery staff, to implement 
                and sustain evidence-based educational and prevention 
                programs;</DELETED>
        <DELETED>    ``(3) campaigns to inform individuals about 
        available resources to aid in recovery from substance use 
        disorder;</DELETED>
        <DELETED>    ``(4) encouragement of individuals in or seeking 
        recovery from substance use disorder to enter the health care 
        system; or</DELETED>
        <DELETED>    ``(5) adult-focused awareness efforts, including 
        efforts focused on older adults, relating to prescription 
        medication disposal, opioid and heroin abuse, signs of 
        overdose, and the use of naloxone for reversal.</DELETED>
<DELETED>    ``(c) Application.--</DELETED>
        <DELETED>    ``(1) In general.--An eligible entity desiring a 
        grant under this section shall submit an application to the 
        Attorney General--</DELETED>
                <DELETED>    ``(A) that meets the criteria under 
                paragraph (2); and</DELETED>
                <DELETED>    ``(B) at such time, in such manner, and 
                accompanied by such information as the Attorney General 
                may require.</DELETED>
        <DELETED>    ``(2) Criteria.--An eligible entity, in submitting 
        an application under paragraph (1), shall--</DELETED>
                <DELETED>    ``(A) describe the evidence-based 
                methodology and outcome measurements that will be used 
                to evaluate the program funded with a grant under this 
                section;</DELETED>
                <DELETED>    ``(B) specifically explain how the 
                measurements described in subparagraph (A) will provide 
                valid measures of the impact of the program described 
                in subparagraph (A);</DELETED>
                <DELETED>    ``(C) describe how the program described 
                in subparagraph (A) could be broadly replicated if 
                demonstrated to be effective;</DELETED>
                <DELETED>    ``(D) demonstrate that all planned 
                services will be research-informed, which may include 
                evidence-based practices documented in--</DELETED>
                        <DELETED>    ``(i) the report of the Institute 
                        of Medicine entitled `Preventing Mental, 
                        Emotional, and Behavioral Disorders Among Young 
                        People'; or</DELETED>
                        <DELETED>    ``(ii) the National Registry of 
                        Effective Programs and Practices (commonly 
                        referred to as `NREPP') of the Substance Abuse 
                        and Mental Health Administration; and</DELETED>
                <DELETED>    ``(E) demonstrate that the eligible entity 
                will effectively integrate and sustain the program 
                described in subparagraph (A) into curriculum or 
                community outreach efforts.</DELETED>
<DELETED>    ``(d) Use of Funds.--A grantee shall use a grant received 
under this section for expenses of educational efforts to--</DELETED>
        <DELETED>    ``(1) prevent abuse of opioids, heroin, alcohol, 
        and other drugs; or</DELETED>
        <DELETED>    ``(2) promote treatment and recovery.</DELETED>
<DELETED>    ``(e) Duration.--The Attorney General shall award grants 
under this section for a period not to exceed 2 years.</DELETED>
<DELETED>    ``(f) Priority Consideration With Respect to States.--In 
awarding grants to States under this section, the Attorney General 
shall give priority to a State that provides civil liability protection 
for first responders, health professionals, and family members 
administering naloxone to counteract opioid overdoses by--</DELETED>
        <DELETED>    ``(1) enacting legislation that provides such 
        civil liability protection; or</DELETED>
        <DELETED>    ``(2) providing a certification by the attorney 
        general of the State that the attorney general has--</DELETED>
                <DELETED>    ``(A) reviewed any applicable civil 
                liability protection law to determine the applicability 
                of the law with respect to first responders, health 
                care professionals, family members, and other 
                individuals who may administer naloxone to individuals 
                reasonably believed to be suffering from opioid 
                overdose; and</DELETED>
                <DELETED>    ``(B) concluded that the law described in 
                subparagraph (A) provides adequate civil liability 
                protection applicable to such persons.</DELETED>
<DELETED>    ``(g) Information Sharing.--The Office of the Attorney 
General, in coordination with the Substance Abuse and Mental Health 
Services Administration and the Department of Education, shall review 
existing evidence-based programs and emerging practices and programs 
and provide information to schools and communities about such programs 
and practices.</DELETED>
<DELETED>    ``(h) Authorization of Appropriations.--There are 
authorized to be appropriated to carry out this section $2,500,000 for 
each of fiscal years 2016 through 2020.''.</DELETED>

<DELETED>SEC. 103. COMMUNITY-BASED COALITION ENHANCEMENT GRANTS TO 
              ADDRESS LOCAL DRUG CRISES.</DELETED>

<DELETED>    Part MM of title I of the Omnibus Crime Control and Safe 
Streets Act of 1968, as added by section 102, is amended by adding at 
the end the following:</DELETED>

<DELETED>``SEC. 3033. COMMUNITY-BASED COALITION ENHANCEMENT GRANTS TO 
              ADDRESS LOCAL DRUG CRISES.</DELETED>

<DELETED>    ``(a) Definitions.--In this section--</DELETED>
        <DELETED>    ``(1) the term `Drug-Free Communities Act of 1997' 
        means chapter 2 of the National Narcotics Leadership Act of 
        1988 (21 U.S.C. 1521 et seq.);</DELETED>
        <DELETED>    ``(2) the term `eligible entity' means an 
        organization that--</DELETED>
                <DELETED>    ``(A) on or before the date of submitting 
                an application for a grant under this section, receives 
                or has received a grant under the Drug-Free Communities 
                Act of 1997; and</DELETED>
                <DELETED>    ``(B) has documented, using local data, 
                rates of abuse of opioids at levels that are--
                </DELETED>
                        <DELETED>    ``(i) significantly higher than 
                        the national average as determined by the 
                        Attorney General (including appropriate 
                        consideration of the Monitoring the Future 
                        Survey published by the National Institute on 
                        Drug Abuse and the National Survey on Drug Use 
                        and Health by the Substance Abuse and Mental 
                        Health Service Administration); or</DELETED>
                        <DELETED>    ``(ii) higher than the national 
                        average, as determined by the Attorney General 
                        (including appropriate consideration of the 
                        surveys described in clause (i)), over a 
                        sustained period of time; and</DELETED>
        <DELETED>    ``(3) the term `local drug crisis' means, with 
        respect to the area served by an eligible entity--</DELETED>
                <DELETED>    ``(A) a sudden increase in the abuse of 
                opioids, as documented by local data; or</DELETED>
                <DELETED>    ``(B) the abuse of prescription 
                medications, specifically opioids, that is 
                significantly higher than the national average, over a 
                sustained period of time, as documented by local 
                data.</DELETED>
<DELETED>    ``(b) Program Authorized.--The Attorney General, in 
coordination with the Director, may make grants to eligible entities to 
implement comprehensive community-wide strategies that address local 
drug crises within the area served by the eligible entity.</DELETED>
<DELETED>    ``(c) Application.--</DELETED>
        <DELETED>    ``(1) In general.--An eligible entity desiring a 
        grant under this section shall submit an application to the 
        Attorney General at such time, in such manner, and accompanied 
        by such information as the Attorney General may 
        require.</DELETED>
        <DELETED>    ``(2) Criteria.--As part of an application for a 
        grant under this section, the Attorney General shall require an 
        eligible entity to submit a detailed, comprehensive, multi-
        sector plan for addressing the local drug crisis within the 
        area served by the eligible entity.</DELETED>
<DELETED>    ``(d) Use of Funds.--An eligible entity shall use a grant 
received under this section--</DELETED>
        <DELETED>    ``(1) for programs designed to implement 
        comprehensive community-wide prevention strategies to address 
        local drug crisis in the area served by the eligible entity, in 
        accordance with the plan submitted under subsection (c)(2); 
        and</DELETED>
        <DELETED>    ``(2) to obtain specialized training and technical 
        assistance from the organization funded under section 4 of 
        Public Law 107-82 (21 U.S.C. 1521 note).</DELETED>
<DELETED>    ``(e) Grant Amounts and Duration.--</DELETED>
        <DELETED>    ``(1) Amounts.--The Attorney General may not award 
        a grant under this section for a fiscal year in an amount that 
        exceeds--</DELETED>
                <DELETED>    ``(A) the amount of non-Federal funds 
                raised by the eligible entity, including in-kind 
                contributions, for that fiscal year; or</DELETED>
                <DELETED>    ``(B) $75,000.</DELETED>
        <DELETED>    ``(2) Duration.--The Attorney General shall award 
        grants under this section for a period not to exceed 4 
        years.</DELETED>
<DELETED>    ``(f) Supplement Not Supplant.--An eligible entity shall 
use Federal funds received under this section only to supplement the 
funds that would, in the absence of those Federal funds, be made 
available from other Federal and non-Federal sources for the activities 
described in this section, and not to supplant those funds.</DELETED>
<DELETED>    ``(g) Evaluation.--A grant under this section shall be 
subject to the same evaluation requirements and procedures as the 
evaluation requirements and procedures imposed on the recipient of a 
grant under the Drug-Free Communities Act of 1997.</DELETED>
<DELETED>    ``(h) Limitation on Administrative Expenses.--Not more 
than 8 percent of the amounts made available pursuant to subsection (i) 
for a fiscal year may be used by the Attorney General to pay for 
administrative expenses.</DELETED>
<DELETED>    ``(i) Authorization of Appropriations.--There are 
authorized to be appropriated to carry out this section $5,000,000 for 
each of fiscal years 2016 through 2020.''.</DELETED>

       <DELETED>TITLE II--LAW ENFORCEMENT AND TREATMENT</DELETED>

<DELETED>SEC. 201. TREATMENT ALTERNATIVE TO INCARCERATION 
              PROGRAMS.</DELETED>

<DELETED>    Part MM of the Omnibus Crime Control and Safe Streets Act 
of 1968, as amended by section 103, is amended by adding at the end the 
following:</DELETED>

<DELETED>``SEC. 3034. TREATMENT ALTERNATIVE TO INCARCERATION 
              PROGRAMS.</DELETED>

<DELETED>    ``(a) Definitions.--In this section--</DELETED>
        <DELETED>    ``(1) the term `eligible entity' means a State, 
        unit of local government, Indian tribe, or nonprofit 
        organization; and</DELETED>
        <DELETED>    ``(2) the term `eligible participant' means an 
        individual who--</DELETED>
                <DELETED>    ``(A) comes into contact with the juvenile 
                justice system or criminal justice system or is 
                arrested or charged with an offense;</DELETED>
                <DELETED>    ``(B) has a history of or a current--
                </DELETED>
                        <DELETED>    ``(i) substance use 
                        disorder;</DELETED>
                        <DELETED>    ``(ii) mental illness; 
                        or</DELETED>
                        <DELETED>    ``(iii) co-occurring mental 
                        illness and substance use disorders; 
                        and</DELETED>
                <DELETED>    ``(C) has been approved for participation 
                in a program funded under this section by, as 
                applicable depending on the stage of the criminal 
                justice process, the relevant law enforcement agency or 
                prosecuting attorney, defense attorney, probation or 
                corrections official, judge, or representative from the 
                relevant mental health or substance abuse 
                agency.</DELETED>
<DELETED>    ``(b) Program Authorized.--The Attorney General may make 
grants to eligible entities to develop, implement, or expand a 
treatment alternative to incarceration program for eligible 
participants, including--</DELETED>
        <DELETED>    ``(1) pre-booking treatment alternative to 
        incarceration programs, including--</DELETED>
                <DELETED>    ``(A) law enforcement training on 
                substance use disorders, mental illness, and co-
                occurring mental illness and substance use 
                disorders;</DELETED>
                <DELETED>    ``(B) receiving centers as alternatives to 
                incarceration of eligible participants;</DELETED>
                <DELETED>    ``(C) specialized response units for calls 
                related to substance use disorders, mental illness, and 
                co-occurring mental illness and substance use 
                disorders; and</DELETED>
                <DELETED>    ``(D) other arrest and pre-booking 
                treatment alternative to incarceration models; 
                and</DELETED>
        <DELETED>    ``(2) post-booking treatment alternative to 
        incarceration programs, including--</DELETED>
                <DELETED>    ``(A) specialized clinical case 
                management;</DELETED>
                <DELETED>    ``(B) pre-trial services related to 
                substances use disorders, mental illness, and co-
                occurring mental illness and substance use 
                disorders;</DELETED>
                <DELETED>    ``(C) prosecutor and defender based 
                programs;</DELETED>
                <DELETED>    ``(D) specialized probation;</DELETED>
                <DELETED>    ``(E) programs utilizing the American 
                Society of Addiction Medicine patient placement 
                criteria;</DELETED>
                <DELETED>    ``(F) treatment and rehabilitation 
                programs and recovery support services; and</DELETED>
                <DELETED>    ``(G) drug courts, DWI courts, and 
                veterans treatment courts.</DELETED>
<DELETED>    ``(c) Application.--</DELETED>
        <DELETED>    ``(1) In general.--An eligible entity desiring a 
        grant under this section shall submit an application to the 
        Attorney General--</DELETED>
                <DELETED>    ``(A) that meets the criteria under 
                paragraph (2); and</DELETED>
                <DELETED>    ``(B) at such time, in such manner, and 
                accompanied by such information as the Attorney General 
                may require.</DELETED>
        <DELETED>    ``(2) Criteria.--An eligible entity, in submitting 
        an application under paragraph (1), shall--</DELETED>
                <DELETED>    ``(A) provide extensive evidence of 
                collaboration with State and local government agencies 
                overseeing health, community corrections, courts, 
                prosecution, substance abuse, mental health, victims 
                services, and employment services, and with local law 
                enforcement agencies;</DELETED>
                <DELETED>    ``(B) demonstrate consultation with the 
                Single State Authority for Substance Abuse;</DELETED>
                <DELETED>    ``(C) demonstrate that evidence-based 
                treatment practices will be utilized; and</DELETED>
                <DELETED>    ``(D) demonstrate that evidenced-based 
                screening and assessment tools will be utilized to 
                place participants in the treatment alternative to 
                incarceration program.</DELETED>
<DELETED>    ``(d) Requirements.--Each eligible entity awarded a grant 
for a treatment alternative to incarceration program under this section 
shall--</DELETED>
        <DELETED>    ``(1) determine the terms and conditions of 
        participation in the program by eligible participants, taking 
        into consideration the collateral consequences of an arrest, 
        prosecution, or criminal conviction;</DELETED>
        <DELETED>    ``(2) ensure that each substance abuse and mental 
        health treatment component is licensed and qualified by the 
        relevant jurisdiction;</DELETED>
        <DELETED>    ``(3) for programs described in subsection (b)(2), 
        organize an enforcement unit comprised of appropriately trained 
        law enforcement professionals under the supervision of the 
        State, tribal, or local criminal justice agency involved, the 
        duties of which shall include--</DELETED>
                <DELETED>    ``(A) the verification of addresses and 
                other contacts of each eligible participant who 
                participates or desires to participate in the program; 
                and</DELETED>
                <DELETED>    ``(B) if necessary, the location, 
                apprehension, arrest, and return to court of an 
                eligible participant in the program who has absconded 
                from the facility of a treatment provider or has 
                otherwise violated the terms and conditions of the 
                program, consistent with Federal and State 
                confidentiality requirements;</DELETED>
        <DELETED>    ``(4) notify the relevant criminal justice entity 
        if any eligible participant in the program absconds from the 
        facility of the treatment provider or otherwise violates the 
        terms and conditions of the program, consistent with Federal 
        and State confidentiality requirements;</DELETED>
        <DELETED>    ``(5) submit periodic reports on the progress of 
        treatment or other measured outcomes from participation in the 
        program of each eligible offender participating in the program 
        to the relevant State, tribal, or local criminal justice 
        agency;</DELETED>
        <DELETED>    ``(6) describe the evidence-based methodology and 
        outcome measurements that will be used to evaluate the program, 
        and specifically explain how such measurements will provide 
        valid measures of the impact of the program; and</DELETED>
        <DELETED>    ``(7) describe how the program could be broadly 
        replicated if demonstrated to be effective.</DELETED>
<DELETED>    ``(e) Use of Funds.--An eligible entity shall use a grant 
received under this section for expenses of a treatment alternative to 
incarceration program, including--</DELETED>
        <DELETED>    ``(1) salaries, personnel costs, equipment costs, 
        and other costs directly related to the operation of the 
        program, including the enforcement unit;</DELETED>
        <DELETED>    ``(2) payments for treatment providers that are 
        approved by the relevant State or tribal jurisdiction and 
        licensed, if necessary, to provide needed treatment to eligible 
        offenders participating in the program, including medication 
        assisted treatment, aftercare supervision, vocational training, 
        education, and job placement; and</DELETED>
        <DELETED>    ``(3) payments to public and nonprofit private 
        entities that are approved by the State or tribal jurisdiction 
        and licensed, if necessary, to provide alcohol and drug 
        addiction treatment and mental health treatment to eligible 
        offenders participating in the program.</DELETED>
<DELETED>    ``(f) Supplement Not Supplant.--An eligible entity shall 
use Federal funds received under this section only to supplement the 
funds that would, in the absence of those Federal funds, be made 
available from other Federal and non-Federal sources for the activities 
described in this section, and not to supplant those funds.</DELETED>
<DELETED>    ``(g) Geographic Distribution.--The Attorney General shall 
ensure that, to the extent practicable, the geographical distribution 
of grants under this section is equitable and includes a grant to an 
eligible entity in--</DELETED>
        <DELETED>    ``(1) each State;</DELETED>
        <DELETED>    ``(2) rural, suburban, and urban areas; 
        and</DELETED>
        <DELETED>    ``(3) tribal jurisdictions.</DELETED>
<DELETED>    ``(h) Priority Consideration With Respect to States.--In 
awarding grants to States under this section, the Attorney General 
shall give priority to a State that provides civil liability protection 
for first responders, health professionals, and family members 
administering naloxone to counteract opioid overdoses by--</DELETED>
        <DELETED>    ``(1) enacting legislation that provides such 
        civil liability protection; or</DELETED>
        <DELETED>    ``(2) providing a certification by the attorney 
        general of the State that the attorney general has--</DELETED>
                <DELETED>    ``(A) reviewed any applicable civil 
                liability protection law to determine the applicability 
                of the law with respect to first responders, health 
                care professionals, family members, and other 
                individuals who may administer naloxone to individuals 
                reasonably believed to be suffering from opioid 
                overdose; and</DELETED>
                <DELETED>    ``(B) concluded that the law described in 
                subparagraph (A) provides adequate civil liability 
                protection applicable to such persons.</DELETED>
<DELETED>    ``(i) Reports and Evaluations.--</DELETED>
        <DELETED>    ``(1) In general.--Each fiscal year, each 
        recipient of a grant under this section during that fiscal year 
        shall submit to the Attorney General a report on the outcomes 
        of activities carried out using that grant in such form, 
        containing such information, and on such dates as the Attorney 
        General shall specify.</DELETED>
        <DELETED>    ``(2) Contents.--A report submitted under 
        paragraph (1) shall--</DELETED>
                <DELETED>    ``(A) describe best practices for 
                treatment alternatives; and</DELETED>
                <DELETED>    ``(B) identify training requirements for 
                law enforcement officers who participate in treatment 
                alternative to incarceration programs.</DELETED>
<DELETED>    ``(j) Authorization of Appropriations.--There are 
authorized to be appropriated to carry out this section $5,000,000 for 
each of fiscal years 2016 through 2020.''.</DELETED>

<DELETED>SEC. 202. LAW ENFORCEMENT NALOXONE TRAINING AND IMPLEMENTATION 
              DEMONSTRATION.</DELETED>

<DELETED>    Part MM of the Omnibus Crime Control and Safe Streets Act 
of 1968, as amended by section 201, is amended by adding at the end the 
following:</DELETED>

<DELETED>``SEC. 3035. LAW ENFORCEMENT NALOXONE TRAINING AND 
              IMPLEMENTATION DEMONSTRATION.</DELETED>

<DELETED>    ``(a) Definition.--In this section, the term `eligible 
entity' means a State, local, or tribal law enforcement 
agency.</DELETED>
<DELETED>    ``(b) Program Authorized.--The Attorney General, in 
coordination with the Secretary of Health and Human Services and the 
Director of the Office of National Drug Control Policy, may make grants 
to eligible entities to create a demonstration law enforcement program 
to prevent opioid and heroin overdose death.</DELETED>
<DELETED>    ``(c) Application.--</DELETED>
        <DELETED>    ``(1) In general.--An eligible entity desiring a 
        grant under this section shall submit an application to the 
        Attorney General--</DELETED>
                <DELETED>    ``(A) that meets the criteria under 
                paragraph (2); and</DELETED>
                <DELETED>    ``(B) at such time, in such manner, and 
                accompanied by such information as the Attorney General 
                may require.</DELETED>
        <DELETED>    ``(2) Criteria.--An eligible entity, in submitting 
        an application under paragraph (1), shall--</DELETED>
                <DELETED>    ``(A) describe the evidence-based 
                methodology and outcome measurements that will be used 
                to evaluate the program funded with a grant under this 
                section, and specifically explain how such measurements 
                will provide valid measures of the impact of the 
                program;</DELETED>
                <DELETED>    ``(B) describe how the program could be 
                broadly replicated if demonstrated to be 
                effective;</DELETED>
                <DELETED>    ``(C) identify the governmental and 
                community agencies that the program will coordinate; 
                and</DELETED>
                <DELETED>    ``(D) describe how law enforcement 
                agencies will coordinate with their corresponding State 
                substance abuse and mental health agencies to identify 
                protocols and resources that are available to victims 
                and families, including information on treatment and 
                recovery resources.</DELETED>
<DELETED>    ``(d) Use of Funds.--An eligible entity shall use a grant 
received under this section to--</DELETED>
        <DELETED>    ``(1) make naloxone available to be carried and 
        administered by law enforcement officers;</DELETED>
        <DELETED>    ``(2) train and provide resources for law 
        enforcement officers on carrying and administering naloxone for 
        the prevention of opioid and heroin overdose death; 
        and</DELETED>
        <DELETED>    ``(3) establish processes, protocols, and 
        mechanisms for referral to treatment.</DELETED>
<DELETED>    ``(e) Grant Amounts and Duration.--</DELETED>
        <DELETED>    ``(1) Maximum amount.--The Attorney General may 
        not award a grant under this section in an amount that exceeds 
        $500,000.</DELETED>
        <DELETED>    ``(2) Duration.--The Attorney General shall award 
        grants under this section for a period not to exceed 2 
        years.</DELETED>
<DELETED>    ``(f) Technical Assistance Grants.--The Attorney General 
shall make a grant for the purpose of providing technical assistance 
and training on the use of naloxone to reverse overdose deaths and 
mechanisms for referral to treatment for an eligible entity receiving a 
grant under this section.</DELETED>
<DELETED>    ``(g) Evaluation.--The Attorney General shall conduct an 
evaluation of grants made under this section to determine--</DELETED>
        <DELETED>    ``(1) the number of officers equipped with 
        naloxone for the prevention of fatal opioid and heroin 
        overdose;</DELETED>
        <DELETED>    ``(2) the number of opioid and heroin overdoses 
        reversed by officers receiving training and supplies of 
        naloxone through a grant received under this section;</DELETED>
        <DELETED>    ``(3) the number of calls for service related to 
        opioid and heroin overdose;</DELETED>
        <DELETED>    ``(4) the extent to which overdose victims and 
        families receive information about treatment services and 
        available data describing treatment admissions; and</DELETED>
        <DELETED>    ``(5) the research, training, and naloxone supply 
        needs of law enforcement and first responder agencies, 
        including those agencies that are not receiving grants under 
        this section.</DELETED>
<DELETED>    ``(h) Authorization of Appropriations.--There are 
authorized to be appropriated to carry out this section $5,000,000 for 
each of fiscal years 2016 through 2020.''.</DELETED>

<DELETED>SEC. 203. PRESCRIPTION DRUG TAKE BACK EXPANSION.</DELETED>

<DELETED>    Part MM of the Omnibus Crime Control and Safe Streets Act 
of 1968, as amended by section 202, is amended by adding at the end the 
following:</DELETED>

<DELETED>``SEC. 3036. PRESCRIPTION DRUG TAKE BACK EXPANSION.</DELETED>

<DELETED>    ``(a) Definition.--In this section, the term `eligible 
entity' means--</DELETED>
        <DELETED>    ``(1) a State, local, or tribal law enforcement 
        agency;</DELETED>
        <DELETED>    ``(2) a manufacturer, distributor, or reverse 
        distributor of prescription medications;</DELETED>
        <DELETED>    ``(3) a retail pharmacy;</DELETED>
        <DELETED>    ``(4) a registered narcotic treatment 
        program;</DELETED>
        <DELETED>    ``(5) a hospital or clinic with an on-site 
        pharmacy;</DELETED>
        <DELETED>    ``(6) an eligible long-term care facility; 
        or</DELETED>
        <DELETED>    ``(7) any other entity authorized by the Drug 
        Enforcement Administration to dispose of prescription 
        medications.</DELETED>
<DELETED>    ``(b) Program Authorized.--The Attorney General, in 
coordination with the Administrator of the Drug Enforcement 
Administration, the Secretary of Health and Human Services, and the 
Director of the Office of National Drug Control Policy, may make grants 
to eligible entities to expand or make available disposal sites for 
unwanted prescription medications.</DELETED>
<DELETED>    ``(c) Application.--</DELETED>
        <DELETED>    ``(1) In general.--An eligible entity desiring a 
        grant under this section shall submit an application to the 
        Attorney General--</DELETED>
                <DELETED>    ``(A) that meets the criteria under 
                paragraph (2); and</DELETED>
                <DELETED>    ``(B) at such time, in such manner, and 
                accompanied by such information as the Attorney General 
                may require.</DELETED>
        <DELETED>    ``(2) Criteria.--An eligible entity, in submitting 
        an application under paragraph (1), shall--</DELETED>
                <DELETED>    ``(A) describe the evidence-based 
                methodology and outcome measurements that will be used 
                to evaluate the program funded with a grant under this 
                section, and specifically explain how such measurements 
                will provide valid measures of the impact of the 
                program;</DELETED>
                <DELETED>    ``(B) describe how the program could be 
                broadly replicated if demonstrated to be effective; 
                and</DELETED>
                <DELETED>    ``(C) identify the governmental and 
                community agencies that will coordinate the 
                program.</DELETED>
<DELETED>    ``(d) Use of Funds.--An eligible entity shall use a grant 
received under this section for--</DELETED>
        <DELETED>    ``(1) expenses of a prescription drug disposal 
        site, including materials and resources;</DELETED>
        <DELETED>    ``(2) implementing disposal procedures and 
        processes;</DELETED>
        <DELETED>    ``(3) implementing community education strategies, 
        including community education materials and 
        resources;</DELETED>
        <DELETED>    ``(4) replicating a prescription drug take back 
        initiative throughout multiple jurisdictions; and</DELETED>
        <DELETED>    ``(5) training of law enforcement officers and 
        other community participants.</DELETED>
<DELETED>    ``(e) Grant Amounts and Duration.--</DELETED>
        <DELETED>    ``(1) Maximum amount.--The Attorney General may 
        not award a grant under this section in an amount that exceeds 
        $250,000.</DELETED>
        <DELETED>    ``(2) Duration.--The Attorney General shall award 
        grants under this section for a period not to exceed 2 
        years.</DELETED>
<DELETED>    ``(f) Technical Assistance Grant.--The Attorney General 
shall make a grant to a national nonprofit organization to provide 
technical assistance and training for an eligible entity receiving a 
grant under this section.</DELETED>
<DELETED>    ``(g) Evaluation.--</DELETED>
        <DELETED>    ``(1) In general.--The Attorney General shall make 
        a grant for evaluation of the performance of each eligible 
        entity receiving a grant under this section.</DELETED>
        <DELETED>    ``(2) Reports.--Each fiscal year, the recipient of 
        a grant under this subsection shall submit to the Attorney 
        General a report that evaluates--</DELETED>
                <DELETED>    ``(A) the effectiveness of the 
                prescription drug take back program of each eligible 
                entity receiving a grant under this section; 
                and</DELETED>
                <DELETED>    ``(B) the effect of disposal efforts on 
                drug circulation.</DELETED>
<DELETED>    ``(h) Authorization of Appropriations.--There are 
authorized to be appropriated to carry out this section $2,500,000 for 
each of fiscal years 2016 through 2020.''.</DELETED>

          <DELETED>TITLE III--TREATMENT AND RECOVERY</DELETED>

<DELETED>SEC. 301. EVIDENCE-BASED OPIOID AND HEROIN TREATMENT AND 
              INTERVENTIONS DEMONSTRATION.</DELETED>

<DELETED>    Subpart 1 of part B of title V of the Public Health 
Service Act (42 U.S.C. 290bb et seq.) is amended--</DELETED>
        <DELETED>    (1) by redesignating section 514 (42 U.S.C. 290bb-
        9), as added by section 3632 of the Methamphetamine Anti-
        Proliferation Act of 2000 (Public Law 106-310; 114 Stat. 1236), 
        as section 514B; and</DELETED>
        <DELETED>    (2) by adding at the end the following:</DELETED>

<DELETED>``SEC. 514C. EVIDENCE-BASED OPIOID AND HEROIN TREATMENT AND 
              INTERVENTIONS DEMONSTRATION.</DELETED>

<DELETED>    ``(a) Grants.--</DELETED>
        <DELETED>    ``(1) Authority to make grants.--The Director of 
        the Center for Substance Abuse Treatment (referred to in this 
        section as the `Director') may award grants to State substance 
        abuse agencies, units of local government, nonprofit 
        organizations, and Indian tribes or tribal organizations (as 
        defined in section 4 of the Indian Health Care Improvement Act 
        (25 U.S.C. 1603)) that have a high rate, or have had a rapid 
        increase, in the use of heroin or other opioids, in order to 
        permit such entities to expand activities, including an 
        expansion in the availability of medication assisted treatment, 
        with respect to the treatment of addiction in the specific 
        geographical areas of such entities where there is a rate or 
        rapid increase in the use of heroin or other opioids.</DELETED>
        <DELETED>    ``(2) Recipients.--The entities receiving grants 
        under paragraph (1) shall be selected by the 
        Director.</DELETED>
        <DELETED>    ``(3) Nature of activities.--The grant funds 
        awarded under paragraph (1) shall be used for activities that 
        are based on reliable scientific evidence of efficacy in the 
        treatment of problems related to heroin or other 
        opioids.</DELETED>
<DELETED>    ``(b) Geographic Distribution.--The Director shall ensure 
that grants awarded under subsection (a) are distributed equitably 
among the various regions of the Nation and among rural, urban, and 
suburban areas that are affected by the use of heroin or other 
opioids.</DELETED>
<DELETED>    ``(c) Additional Activities.--The Director shall--
</DELETED>
        <DELETED>    ``(1) evaluate the activities supported by grants 
        awarded under subsection (a);</DELETED>
        <DELETED>    ``(2) disseminate widely such significant 
        information derived from the evaluation as the Director 
        considers appropriate;</DELETED>
        <DELETED>    ``(3) provide States, Indian tribes and tribal 
        organizations, and providers with technical assistance in 
        connection with the provision of treatment of problems related 
        to heroin and other opioids; and</DELETED>
        <DELETED>    ``(4) fund only those applications that 
        specifically support recovery services as a critical component 
        of the grant program.</DELETED>
<DELETED>    ``(d) Definition.--The term `medication assisted 
treatment' means the use, for problems relating to heroin and other 
opioids, of medications approved by the Food and Drug Administration in 
combination with counseling and behavioral therapies.</DELETED>
<DELETED>    ``(e) Authorization of Appropriations.--</DELETED>
        <DELETED>    ``(1) In general.--There are authorized to be 
        appropriated to carry out this section $12,000,000 for fiscal 
        year 2016 and such sums as may be necessary for each of fiscal 
        years 2016 through 2020.</DELETED>
        <DELETED>    ``(2) Use of certain funds.--Of the funds 
        appropriated to carry out this section in any fiscal year, the 
        lesser of 5 percent of such funds or $1,000,000 shall be 
        available to the Director for purposes of carrying out 
        subsection (c).''.</DELETED>

<DELETED>SEC. 302. CRIMINAL JUSTICE MEDICATION ASSISTED TREATMENT AND 
              INTERVENTIONS DEMONSTRATION.</DELETED>

<DELETED>    Part MM of the Omnibus Crime Control and Safe Streets Act 
of 1968, as amended by section 203, is amended by adding at the end the 
following:</DELETED>

<DELETED>``SEC. 3037. CRIMINAL JUSTICE MEDICATION ASSISTED TREATMENT 
              AND INTERVENTIONS DEMONSTRATION.</DELETED>

<DELETED>    ``(a) Definitions.--In this section--</DELETED>
        <DELETED>    ``(1) the term `criminal justice agency' means a 
        State, local, or tribal--</DELETED>
                <DELETED>    ``(A) court;</DELETED>
                <DELETED>    ``(B) prison;</DELETED>
                <DELETED>    ``(C) jail; or</DELETED>
                <DELETED>    ``(D) other agency that performs the 
                administration of criminal justice, including 
                prosecution, pretrial services, and community 
                supervision; and</DELETED>
        <DELETED>    ``(2) the term `eligible entity' means a State, 
        unit of local government, or Indian tribe.</DELETED>
<DELETED>    ``(b) Program Authorized.--The Attorney General, in 
coordination with the Secretary of Health and Human Services and the 
Director of the Office of National Drug Control Policy, may make grants 
to eligible entities to implement medication assisted treatment 
programs through criminal justice agencies.</DELETED>
<DELETED>    ``(c) Application.--</DELETED>
        <DELETED>    ``(1) In general.--An eligible entity desiring a 
        grant under this section shall submit an application to the 
        Attorney General--</DELETED>
                <DELETED>    ``(A) that meets the criteria under 
                paragraph (2); and</DELETED>
                <DELETED>    ``(B) at such time, in such manner, and 
                accompanied by such information as the Attorney General 
                may require.</DELETED>
        <DELETED>    ``(2) Criteria.--An eligible entity, in submitting 
        an application under paragraph (1), shall--</DELETED>
                <DELETED>    ``(A) certify that each medication 
                assisted treatment program funded with a grant under 
                this section has been developed in consultation with 
                the Single State Authority for Substance Abuse; 
                and</DELETED>
                <DELETED>    ``(B) describe how data will be collected 
                and analyzed to determine the effectiveness of the 
                program described in subparagraph (A).</DELETED>
<DELETED>    ``(d) Use of Funds.--An eligible entity shall use a grant 
received under this section for expenses of--</DELETED>
        <DELETED>    ``(1) a medication assisted treatment program, 
        including the expenses of prescribing medications recognized by 
        the Food and Drug Administration for opioid treatment in 
        conjunction with psychological and behavioral 
        therapy;</DELETED>
        <DELETED>    ``(2) training criminal justice agency personnel 
        and treatment providers on medication assisted 
        treatment;</DELETED>
        <DELETED>    ``(3) cross-training personnel providing 
        behavioral health and health services, administration of 
        medicines, and other administrative expenses, including 
        required reports; and</DELETED>
        <DELETED>    ``(4) the provision of recovery coaches who are 
        responsible for providing mentorship and transition plans to 
        individuals reentering society following incarceration or 
        alternatives to incarceration.</DELETED>
<DELETED>    ``(e) Grant Amounts and Duration.--</DELETED>
        <DELETED>    ``(1) Maximum amount.--The Attorney General may 
        not award a grant under this section in an amount that exceeds 
        $750,000.</DELETED>
        <DELETED>    ``(2) Duration.--The Attorney General shall award 
        grants under this section for a period not to exceed 2 
        years.</DELETED>
<DELETED>    ``(f) Priority Consideration With Respect to States.--In 
awarding grants to States under this section, the Attorney General 
shall give priority to a State that provides civil liability protection 
for first responders, health professionals, and family members 
administering naloxone to counteract opioid overdoses by--</DELETED>
        <DELETED>    ``(1) enacting legislation that provides such 
        civil liability protection; or</DELETED>
        <DELETED>    ``(2) providing a certification by the attorney 
        general of the State that the attorney general has--</DELETED>
                <DELETED>    ``(A) reviewed any applicable civil 
                liability protection law to determine the applicability 
                of the law with respect to first responders, health 
                care professionals, family members, and other 
                individuals who may administer naloxone to individuals 
                reasonably believed to be suffering from opioid 
                overdose; and</DELETED>
                <DELETED>    ``(B) concluded that the law described in 
                subparagraph (A) provides adequate civil liability 
                protection applicable to such persons.</DELETED>
<DELETED>    ``(g) Technical Assistance.--The Attorney General, in 
coordination with the Director of the National Institute on Drug Abuse 
and the Secretary of Health and Human Services, shall provide technical 
assistance and training for an eligible entity receiving a grant under 
this section.</DELETED>
<DELETED>    ``(h) Reports.--</DELETED>
        <DELETED>    ``(1) In general.--An eligible entity receiving a 
        grant under this subsection shall submit a report to the 
        Attorney General on the outcomes of each grant received under 
        this section for individuals receiving medication assisted 
        treatment, based on--</DELETED>
                <DELETED>    ``(A) the recidivism of the 
                individuals;</DELETED>
                <DELETED>    ``(B) the treatment outcomes of the 
                individuals, including maintaining abstinence from 
                illegal, unauthorized, and unprescribed or undispensed 
                opioids and heroin;</DELETED>
                <DELETED>    ``(C) a comparison of the cost of 
                providing medication assisted treatment to the cost of 
                incarceration or other participation in the criminal 
                justice system;</DELETED>
                <DELETED>    ``(D) the housing status of the 
                individuals; and</DELETED>
                <DELETED>    ``(E) the employment status of the 
                individuals.</DELETED>
        <DELETED>    ``(2) Contents and timing.--Each report described 
        in paragraph (1) shall be submitted annually in such form, 
        containing such information, and on such dates as the Attorney 
        General shall specify.</DELETED>
<DELETED>    ``(i) Authorization of Appropriations.--There are 
authorized to be appropriated to carry out this section $5,000,000 for 
each of fiscal years 2016 through 2020.''.</DELETED>

<DELETED>SEC. 303. NATIONAL YOUTH RECOVERY INITIATIVE.</DELETED>

<DELETED>    (a) Definitions.--In this section:</DELETED>
        <DELETED>    (1) Eligible entity.--The term ``eligible entity'' 
        means--</DELETED>
                <DELETED>    (A) a high school that has been accredited 
                as a recovery high school by the Association of 
                Recovery Schools;</DELETED>
                <DELETED>    (B) an accredited high school that is 
                seeking to establish or expand recovery support 
                services;</DELETED>
                <DELETED>    (C) an institution of higher 
                education;</DELETED>
                <DELETED>    (D) a recovery program at a nonprofit 
                collegiate institution; or</DELETED>
                <DELETED>    (E) a nonprofit organization.</DELETED>
        <DELETED>    (2) Institution of higher education.--The term 
        ``institution of higher education'' has the meaning given the 
        term in section 101 of the Higher Education Act of 1965 (20 
        U.S.C. 1001).</DELETED>
        <DELETED>    (3) Recovery program.--The term ``recovery 
        program''--</DELETED>
                <DELETED>    (A) means a program to help individuals 
                who are recovering from substance use disorders to 
                initiate, stabilize, and maintain healthy and 
                productive lives in the community; and</DELETED>
                <DELETED>    (B) includes peer-to-peer support and 
                communal activities to build recovery skills and 
                supportive social networks.</DELETED>
<DELETED>    (b) Grants Authorized.--The ONDCP Recovery Branch, in 
consultation with the Secretary of Education, may award grants to 
eligible entities to enable the entities to--</DELETED>
        <DELETED>    (1) provide substance use recovery support 
        services to young people in high school and enrolled in 
        institutions of higher education;</DELETED>
        <DELETED>    (2) help build communities of support for young 
        people in recovery through a spectrum of activities such as 
        counseling and healthy and wellness-oriented social activities; 
        and</DELETED>
        <DELETED>    (3) encourage initiatives designed to help young 
        people achieve and sustain recovery from substance use 
        disorders.</DELETED>
<DELETED>    (c) Use of Funds.--Grants awarded under subsection (b) may 
be used for activities to develop, support, and maintain youth recovery 
support services, including--</DELETED>
        <DELETED>    (1) the development and maintenance of a dedicated 
        physical space for recovery programs;</DELETED>
        <DELETED>    (2) dedicated staff for the provision of recovery 
        programs;</DELETED>
        <DELETED>    (3) healthy and wellness-oriented social 
        activities and community engagement;</DELETED>
        <DELETED>    (4) establishment of recovery high 
        schools;</DELETED>
        <DELETED>    (5) coordination of recovery programs with--
        </DELETED>
                <DELETED>    (A) substance use disorder treatment 
                programs and systems;</DELETED>
                <DELETED>    (B) providers of mental health 
                services;</DELETED>
                <DELETED>    (C) primary care providers;</DELETED>
                <DELETED>    (D) the criminal justice system, including 
                the juvenile justice system;</DELETED>
                <DELETED>    (E) employers;</DELETED>
                <DELETED>    (F) housing services;</DELETED>
                <DELETED>    (G) child welfare services;</DELETED>
                <DELETED>    (H) institutions of secondary higher 
                education and institutions of higher education; 
                and</DELETED>
                <DELETED>    (I) other programs or services related to 
                the welfare of an individual in recovery from a 
                substance use disorder;</DELETED>
        <DELETED>    (6) the development of peer-to-peer support 
        programs or services; and</DELETED>
        <DELETED>    (7) additional activities that help youths and 
        young adults to achieve recovery from substance use 
        disorders.</DELETED>
<DELETED>    (d) Resource Center.--The ONDCP Recovery Branch shall 
establish a resource center to provide technical support to recipients 
of grants under this section.</DELETED>
<DELETED>    (e) Authorization of Appropriations.--There are authorized 
to be appropriated to carry out this section $3,000,000 for fiscal year 
2016 and each of the 5 succeeding fiscal years.</DELETED>

<DELETED>SEC. 304. BUILDING COMMUNITIES OF RECOVERY.</DELETED>

<DELETED>    (a) Definition.--In this section, the term ``recovery 
community organization'' means an independent nonprofit organization 
that--</DELETED>
        <DELETED>    (1) mobilizes resources within and outside of the 
        recovery community to increase the prevalence and quality of 
        long-term recovery from substance use disorders; and</DELETED>
        <DELETED>    (2) is wholly or principally governed by people in 
        recovery for substance use disorders who reflect the community 
        served.</DELETED>
<DELETED>    (b) Grants Authorized.--The ONDCP Recovery Branch, in 
consultation with the Substance Abuse and Mental Health Services 
Administration, may award grants to recovery community organizations to 
enable such organizations to develop, expand, and enhance recovery 
services.</DELETED>
<DELETED>    (c) Maximum Grant Amount.--The ONDCP Recovery Branch may 
not award a grant under this section in an amount that exceeds 
$200,000.</DELETED>
<DELETED>    (d) Federal Share.--The Federal share of the costs of a 
program funded by a grant under this section may not exceed 50 
percent.</DELETED>
<DELETED>    (e) Use of Funds.--Grants awarded under subsection (b)--
</DELETED>
        <DELETED>    (1) shall be used to develop, expand, and enhance 
        community and statewide recovery support services; 
        and</DELETED>
        <DELETED>    (2) may be used to--</DELETED>
                <DELETED>    (A) advocate for individuals in recovery 
                from substance use disorders;</DELETED>
                <DELETED>    (B) build connections between recovery 
                networks, between recovery community organizations, and 
                with other recovery support services, including--
                </DELETED>
                        <DELETED>    (i) substance use disorder 
                        treatment programs and systems;</DELETED>
                        <DELETED>    (ii) providers of mental health 
                        services;</DELETED>
                        <DELETED>    (iii) primary care 
                        providers;</DELETED>
                        <DELETED>    (iv) the criminal justice 
                        system;</DELETED>
                        <DELETED>    (v) employers;</DELETED>
                        <DELETED>    (vi) housing services;</DELETED>
                        <DELETED>    (vii) child welfare agencies; 
                        and</DELETED>
                        <DELETED>    (viii) other recovery support 
                        services that facilitate recovery from 
                        substance use disorders;</DELETED>
                <DELETED>    (C) reduce the stigma associated with 
                substance use disorders;</DELETED>
                <DELETED>    (D) conduct public education and outreach 
                on issues relating to substance use disorders and 
                recovery, including--</DELETED>
                        <DELETED>    (i) how to identify the signs of 
                        addiction;</DELETED>
                        <DELETED>    (ii) the resources that are 
                        available for individuals struggling with 
                        addiction;</DELETED>
                        <DELETED>    (iii) the resources that are 
                        available to help support individuals in 
                        recovery; and</DELETED>
                        <DELETED>    (iv) information on the medical 
                        consequences of substance use disorders, 
                        including neonatal abstinence syndrome and 
                        potential infection with human immunodeficiency 
                        virus and viral hepatitis; and</DELETED>
                <DELETED>    (E) carry out other activities that 
                strengthen the network of community support for 
                individuals in recovery.</DELETED>
<DELETED>    (f) Resource Center.--The ONDCP Recovery Branch shall 
establish a resource center to provide technical assistance to 
recipients of grants under this section and to provide information to 
individuals seeking to support people in recovery from substance use 
disorders.</DELETED>
<DELETED>    (g) Authorization of Appropriations.--There are authorized 
to be appropriated to carry out this section $5,700,000 in fiscal year 
2016 and each of the 3 succeeding fiscal years.</DELETED>

    <DELETED>TITLE IV--ADDRESSING COLLATERAL CONSEQUENCES</DELETED>

<DELETED>SEC. 401. CORRECTIONAL EDUCATION DEMONSTRATION GRANT 
              PROGRAM.</DELETED>

<DELETED>    Title I of the Omnibus Crime Control and Safe Streets Act 
of 1968 (42 U.S.C. 3711 et seq.) is amended--</DELETED>
        <DELETED>    (1) by redesignating part KK as part LL;</DELETED>
        <DELETED>    (2) by redesignating sections 3011 and 3012 as 
        sections 3021 and 3022, respectively; and</DELETED>
        <DELETED>    (3) by inserting before part LL, as redesignated, 
        the following:</DELETED>

    <DELETED>``PART KK--CORRECTIONAL EDUCATION DEMONSTRATION GRANT 
                           PROGRAM</DELETED>

<DELETED>``SEC. 3011. CORRECTIONAL EDUCATION DEMONSTRATION GRANT 
              PROGRAM.</DELETED>

<DELETED>    ``(a) Definition.--In this section, the term `eligible 
entity' means a State, unit of local government, nonprofit 
organization, or Indian tribe.</DELETED>
<DELETED>    ``(b) Grant Program Authorized.--The Attorney General may 
make grants of not more than $750,000 to eligible entities to design, 
implement, and expand educational programs for offenders in prisons, 
jails, and juvenile facilities, including to pay for--</DELETED>
        <DELETED>    ``(1) basic education, secondary level academic 
        education, high school equivalency examination preparation, 
        career technical education, and English as a second language 
        instruction at the basic, secondary, or post-secondary levels, 
        for adult and juvenile populations;</DELETED>
        <DELETED>    ``(2) screening and assessment of inmates to 
        assess education level, needs, occupational interest or 
        aptitude, risk level, and other needs, and case management 
        services;</DELETED>
        <DELETED>    ``(3) hiring and training of instructors and 
        aides, reimbursement of non-corrections staff and experts, 
        reimbursement of stipends paid to inmate tutors or aides, and 
        the costs of training inmate tutors and aides;</DELETED>
        <DELETED>    ``(4) instructional supplies and equipment, 
        including occupational program supplies and equipment to the 
        extent that the supplies and equipment are used for 
        instructional purposes;</DELETED>
        <DELETED>    ``(5) partnerships and agreements with community 
        colleges, universities, and career technology education program 
        providers, including tuition payments;</DELETED>
        <DELETED>    ``(6) certification programs providing recognized 
        high school equivalency certificates and industry recognized 
        credentials; and</DELETED>
        <DELETED>    ``(7) technology solutions to--</DELETED>
                <DELETED>    ``(A) meet the instructional, assessment, 
                and information needs of correctional populations; 
                and</DELETED>
                <DELETED>    ``(B) facilitate the continued 
                participation of incarcerated students in community-
                based education programs after the students are 
                released from incarceration.</DELETED>
<DELETED>    ``(c) Application.--An eligible entity desiring a grant 
under this section shall submit to the Attorney General an application 
in such form and manner, at such time, and accompanied by such 
information as the Attorney General specifies.</DELETED>
<DELETED>    ``(d) Priority Considerations.--In awarding grants under 
this section, the Attorney General shall give priority to applicants 
that--</DELETED>
        <DELETED>    ``(1) assess the level of risk and need of 
        inmates, including by--</DELETED>
                <DELETED>    ``(A) assessing the need for English as a 
                second language instruction;</DELETED>
                <DELETED>    ``(B) conducting educational assessments; 
                and</DELETED>
                <DELETED>    ``(C) assessing occupational interests and 
                aptitudes;</DELETED>
        <DELETED>    ``(2) target educational services to assessed 
        needs, including academic and occupational at the basic, 
        secondary, or post-secondary level;</DELETED>
        <DELETED>    ``(3) target career technology education programs 
        to--</DELETED>
                <DELETED>    ``(A) areas of identified occupational 
                demand; and</DELETED>
                <DELETED>    ``(B) employment opportunities in the 
                communities in which students are reasonably expected 
                to reside post-release;</DELETED>
        <DELETED>    ``(4) include a range of appropriate educational 
        opportunities at the basic, secondary, and post-secondary 
        levels;</DELETED>
        <DELETED>    ``(5) include opportunities for students to attain 
        industry recognized credentials;</DELETED>
        <DELETED>    ``(6) include partnership or articulation 
        agreements linking institutional education programs with 
        community sited programs provided by adult education program 
        providers and accredited institutions of higher education, 
        community colleges, and vocational training institutions; 
        and</DELETED>
        <DELETED>    ``(7) explicitly include career pathways models 
        offering opportunities for incarcerated students to develop 
        academic skills, in-demand occupational skills and credentials, 
        occupational experience in institutional work programs or work 
        release programs, and linkages with employers in the community, 
        so that incarcerated students have opportunities to embark on 
        careers with strong prospects for both post-release employment 
        and advancement in a career ladder over time.</DELETED>
<DELETED>    ``(e) Requirements.--An eligible entity desiring a grant 
under this section shall--</DELETED>
        <DELETED>    ``(1) describe the evidence-based methodology and 
        outcome measurements that will be used to evaluate each program 
        funded with a grant under this section, and specifically 
        explain how such measurements will provide valid measures of 
        the impact of the program; and</DELETED>
        <DELETED>    ``(2) describe how the program described in 
        paragraph (1) could be broadly replicated if demonstrated to be 
        effective.</DELETED>
<DELETED>    ``(f) Control of Internet Access.--An entity that receives 
a grant under this section shall restrict access to the Internet by 
prisoners, as appropriate, to ensure public safety.</DELETED>

<DELETED>``SEC. 3012. AUTHORIZATION OF APPROPRIATIONS.</DELETED>

<DELETED>    ``There are authorized to be appropriated $5,000,000 to 
carry out this part for fiscal years 2016 through 2020.''.</DELETED>

<DELETED>SEC. 402. REVISION OF FAFSA FORM.</DELETED>

<DELETED>    Section 483 of the Higher Education Act of 1965 (20 U.S.C. 
1090) is amended by adding at the end the following:</DELETED>
<DELETED>    ``(i) Convictions.--The Secretary shall not include any 
question about the conviction of an applicant for the possession or 
sale of illegal drugs on the FAFSA (or any other form developed under 
subsection (a)).''.</DELETED>

<DELETED>SEC. 403. NATIONAL TASK FORCE ON RECOVERY AND COLLATERAL 
              CONSEQUENCES.</DELETED>

<DELETED>    (a) Definition.--In this section, the term ``collateral 
consequence'' means a penalty, disability, or disadvantage--</DELETED>
        <DELETED>    (1) imposed on an individual as a result of a 
        criminal conviction but not as part of the judgment of the 
        court that imposes the conviction; or</DELETED>
        <DELETED>    (2) that an administrative agency, official, or 
        civil court is authorized, but not required, to impose on an 
        individual convicted of a felony, misdemeanor, or other 
        criminal offense.</DELETED>
<DELETED>    (b) Establishment.--</DELETED>
        <DELETED>    (1) In general.--Not later than 30 days after the 
        date of enactment of this Act, the Secretary of Health and 
        Human Services (in this section referred to as the 
        ``Secretary'') shall establish a bipartisan task force to be 
        known as the Task Force on Recovery and Collateral Consequences 
        (in this section referred to as the ``Task Force'').</DELETED>
        <DELETED>    (2) Membership.--</DELETED>
                <DELETED>    (A) Total number of members.--The Task 
                Force shall include 10 members, who shall be appointed 
                by the Secretary in accordance with subparagraphs (B) 
                and (C).</DELETED>
                <DELETED>    (B) Members of the task force.--The Task 
                Force shall include--</DELETED>
                        <DELETED>    (i) members who have national 
                        recognition and significant expertise in areas 
                        such as health care, housing, employment, 
                        substance use disorder, mental health, law 
                        enforcement, and law;</DELETED>
                        <DELETED>    (ii) not fewer than 2 members--
                        </DELETED>
                                <DELETED>    (I) who have personally 
                                experienced substance abuse or 
                                addiction and are in recovery; 
                                and</DELETED>
                                <DELETED>    (II) not fewer than 1 one 
                                of whom has benefited from medication 
                                assisted treatment; and</DELETED>
                        <DELETED>    (iii) to the extent practicable, 
                        members who formerly served as elected 
                        officials at the State and Federal 
                        levels.</DELETED>
                <DELETED>    (C) Timing.--The Secretary shall appoint 
                the members of the Task Force not later than 60 days 
                after the date on which the Task Force is established 
                under paragraph (1).</DELETED>
        <DELETED>    (3) Chairperson.--The Task Force shall select a 
        chairperson or co-chairpersons from among the members of the 
        Task Force.</DELETED>
<DELETED>    (c) Duties of the Task Force.--</DELETED>
        <DELETED>    (1) In general.--The Task Force shall--</DELETED>
                <DELETED>    (A) identify collateral consequences for 
                individuals with Federal or State drug convictions who 
                are in recovery for substance use disorder; 
                and</DELETED>
                <DELETED>    (B) determine whether the collateral 
                consequences identified under subparagraph (A) 
                unnecessarily delay individuals in recovery from 
                resuming their personal and professional 
                activities.</DELETED>
        <DELETED>    (2) Recommendations.--Not later than 180 days 
        after the date of the first meeting of the Task Force, the Task 
        Force shall develop recommendations for proposed legislative 
        and regulatory changes to reduce and, to the extent 
        practicable, eliminate the collateral consequences identified 
        by the Task Force under paragraph (1).</DELETED>
        <DELETED>    (3) Collection of information.--The Task Force 
        shall hold hearings, require the testimony and attendance of 
        witnesses, and secure information from any department or agency 
        of the United States in performing the duties under paragraphs 
        (1) and (2).</DELETED>
        <DELETED>    (4) Report.--Not later than 1 year after the date 
        of the first meeting of the Task Force, the Task Force shall 
        submit a report detailing the findings and recommendations of 
        the Task Force to--</DELETED>
                <DELETED>    (A) each relevant committee of 
                Congress;</DELETED>
                <DELETED>    (B) the head of each relevant department 
                or agency of the United States;</DELETED>
                <DELETED>    (C) the President; and</DELETED>
                <DELETED>    (D) the Vice President.</DELETED>

<DELETED>TITLE V--ADDICTION AND TREATMENT SERVICES FOR WOMEN, FAMILIES, 
                         AND VETERANS</DELETED>

<DELETED>SEC. 501. AUTHORITY TO AWARD COMPETITIVE GRANTS TO ADDRESS 
              OPIOID AND HEROIN ABUSE BY PREGNANT AND PARENTING FEMALE 
              OFFENDERS.</DELETED>

<DELETED>    Part MM of the Omnibus Crime Control and Safe Streets Act 
of 1968, as amended by section 302, is amended by adding at the end the 
following:</DELETED>

<DELETED>``SEC. 3038. AUTHORITY TO AWARD COMPETITIVE GRANTS TO ADDRESS 
              OPIOID AND HEROIN ABUSE BY PREGNANT AND PARENTING FEMALE 
              OFFENDERS.</DELETED>

<DELETED>    ``(a) Definitions.--In this section--</DELETED>
        <DELETED>    ``(1) the term `State criminal justice agency' 
        means the agency of the State responsible for administering 
        criminal justice funds, including the Edward Byrne Memorial 
        Justice Assistance Grant Program under subpart 1 of part E; 
        and</DELETED>
        <DELETED>    ``(2) the term `State substance abuse agency' 
        means the agency of the State responsible for the State 
        prevention, treatment, and recovery system, including 
        management of the Substance Abuse Prevention and Treatment 
        Block Grant under subpart II of part B of title XIX of the 
        Public Health Service Act (42 U.S.C. 300x-21 et 
        seq.).</DELETED>
<DELETED>    ``(b) Purpose and Program Authority.--</DELETED>
        <DELETED>    ``(1) Grant authorization.--The Attorney General, 
        in coordination with the Secretary of Health and Human 
        Services, may award competitive grants jointly to a State 
        substance abuse agency and a State criminal justice agency to 
        address the use of opioids and heroin among pregnant and 
        parenting female offenders in the State to promote public 
        safety, public health, family permanence, and well-
        being.</DELETED>
        <DELETED>    ``(2) Purposes and program authority.--A grant 
        under this section shall be used to facilitate or enhance 
        collaboration between the State criminal justice and State 
        substance abuse systems in order to carry out programs to 
        address the use of opioid and heroin abuse by pregnant and 
        parenting female offenders.</DELETED>
<DELETED>    ``(c) Applications.--</DELETED>
        <DELETED>    ``(1) In general.--A State substance abuse agency 
        and State criminal justice agency desiring a grant under this 
        section shall jointly submit to the Attorney General an 
        application in such form, and containing such information, as 
        the Attorney General may prescribe by regulation or 
        guidelines.</DELETED>
        <DELETED>    ``(2) Contents.--</DELETED>
                <DELETED>    ``(A) In general.--Each application for a 
                grant under this section shall contain a plan to expand 
                the services of the State for pregnant and parenting 
                female offenders for the use of opioids, heroin, and 
                other drugs, which shall be in accordance with 
                regulations or guidelines established by the Attorney 
                General, in consultation with the Secretary of Health 
                and Human Services.</DELETED>
                <DELETED>    ``(B) Plan.--A plan submitted under 
                subparagraph (A) shall, at a minimum, include--
                </DELETED>
                        <DELETED>    ``(i) a description of how the 
                        applicants will work jointly to address the 
                        needs associated with the use of opioids or 
                        heroin by pregnant and parenting female 
                        offenders to promote family stability and 
                        permanence;</DELETED>
                        <DELETED>    ``(ii) a description of the nature 
                        and the extent of the problem of opioid and 
                        heroin use by pregnant and parenting female 
                        offenders in the State;</DELETED>
                        <DELETED>    ``(iii) a certification that the 
                        State has involved counties and other units of 
                        local government, when appropriate, in the 
                        development, expansion, modification, 
                        operation, or improvement of proposed programs 
                        to address the problems associated with opioid 
                        and heroin use;</DELETED>
                        <DELETED>    ``(iv) a certification that funds 
                        received under this section will be used to 
                        supplement, not supplant, other Federal, State, 
                        and local funds; and</DELETED>
                        <DELETED>    ``(v) a description of clinically 
                        appropriate practices and procedures to--
                        </DELETED>
                                <DELETED>    ``(I) screen and assess 
                                pregnant and parenting female offenders 
                                for problems associated with opioids 
                                and heroin;</DELETED>
                                <DELETED>    ``(II) screen and assess 
                                pregnant and parenting female offenders 
                                demonstrating problems associated with 
                                opioids and heroin for co-occurring 
                                mental disorders;</DELETED>
                                <DELETED>    ``(III) provide clinically 
                                appropriate services, including 
                                medication assisted treatment, for 
                                female offenders and their children in 
                                the same location to promote family 
                                permanence and self-sufficiency; 
                                and</DELETED>
                                <DELETED>    ``(IV) provide for a 
                                process to enhance or ensure the 
                                abilities of the State criminal justice 
                                agency and State substance abuse agency 
                                to work together to reunite families 
                                when appropriate in the case where 
                                family treatment is not 
                                provided.</DELETED>
<DELETED>    ``(d) Period of Grant; Renewal.--</DELETED>
        <DELETED>    ``(1) Period.--A grant under this section shall be 
        for a period of 3 years.</DELETED>
        <DELETED>    ``(2) Renewal.--A State substance abuse agency and 
        a State criminal justice agency receiving a grant under this 
        section may apply for and, after the end of the period of the 
        first grant under this section, receive 1 additional grant 
        under this section.</DELETED>
<DELETED>    ``(e) Performance Accountability; Reports.--</DELETED>
        <DELETED>    ``(1) Reports.--A State substance abuse agency and 
        a State criminal justice agency receiving a grant under this 
        section shall jointly submit to the Attorney General a report 
        on the activities carried out under the grant at the end of 
        each fiscal year during the period of the grant.</DELETED>
        <DELETED>    ``(2) Evaluation.--Not later than 1 year after the 
        end of the period of a grant under this section, the Attorney 
        General shall submit a report to each committee of Congress 
        with jurisdiction of the program under this section that 
        summarizes the reports of the recipients of the grant and 
        provides recommendations, if any, for further legislative 
        action.</DELETED>
<DELETED>    ``(f) Training and Technical Assistance.--The Attorney 
General shall support State substance abuse and State criminal justice 
agencies by developing, in consultation with State substance abuse and 
State criminal justice agencies, and offering a program of training and 
technical assistance to assist the agencies in developing programs and 
protocols--</DELETED>
        <DELETED>    ``(1) to implement this section; and</DELETED>
        <DELETED>    ``(2) for effectively working across the Federal 
        and State criminal and substance abuse systems.</DELETED>
<DELETED>    ``(g) Authorization of Appropriations.--There are 
authorized to be appropriated to carry out this section $5,000,000 for 
each of fiscal years 2016 through 2020.''.</DELETED>

<DELETED>SEC. 502. GRANTS FOR FAMILY-BASED SUBSTANCE ABUSE 
              TREATMENT.</DELETED>

<DELETED>    Section 2925 of the Omnibus Crime Control and Safe Streets 
Act of 1968 (42 U.S.C. 3797s-4) is amended--</DELETED>
        <DELETED>    (1) by striking ``An entity'' and inserting ``(a) 
        Entity Reports.--An entity''; and</DELETED>
        <DELETED>    (2) by adding at the end the following:</DELETED>
<DELETED>    ``(b) Attorney General Report on Family-Based Substance 
Abuse Treatment.--The Attorney General shall submit to Congress an 
annual report that describes the number of grants awarded under section 
2921(1) and how such grants are used by the recipients for family-based 
substance abuse treatment programs that serve as alternatives to 
incarceration for custodial parents to receive treatment and services 
as a family.''.</DELETED>

<DELETED>SEC. 503. VETERANS' TREATMENT COURTS.</DELETED>

<DELETED>    Section 2991 of the Omnibus Crime Control and Safe Streets 
Act of 1968 (42 U.S.C. 3797aa) is amended--</DELETED>
        <DELETED>    (1) by redesignating subsection (i) as subsection 
        (j);</DELETED>
        <DELETED>    (2) by inserting after subsection (h) the 
        following:</DELETED>
<DELETED>    ``(i) Assisting Veterans.--</DELETED>
        <DELETED>    ``(1) Definitions.--In this subsection:</DELETED>
                <DELETED>    ``(A) Peer to peer services or programs.--
                The term `peer to peer services or programs' means 
                services or programs that connect qualified veterans 
                with other veterans for the purpose of providing 
                support and mentorship to assist qualified veterans in 
                obtaining treatment, recovery, stabilization, or 
                rehabilitation.</DELETED>
                <DELETED>    ``(B) Qualified veteran.--The term 
                `qualified veteran' means a preliminarily qualified 
                offender who--</DELETED>
                        <DELETED>    ``(i) has served on active duty in 
                        any branch of the Armed Forces, including the 
                        National Guard and reserve components; 
                        and</DELETED>
                        <DELETED>    ``(ii)(I) was discharged or 
                        released from such service under conditions 
                        other than dishonorable; or</DELETED>
                        <DELETED>    ``(II) was discharged or released 
                        from such service under dishonorable 
                        conditions, if the reason for that discharge or 
                        release, if known, is attributable to drug 
                        use.</DELETED>
                <DELETED>    ``(C) Veterans treatment court program.--
                The term `veterans treatment court program' means a 
                court program involving collaboration among criminal 
                justice, veterans, and mental health and substance 
                abuse agencies that provides qualified veterans with--
                </DELETED>
                        <DELETED>    ``(i) intensive judicial 
                        supervision and case management, which may 
                        include random and frequent drug testing where 
                        appropriate;</DELETED>
                        <DELETED>    ``(ii) a full continuum of 
                        treatment services, including mental health 
                        services, substance abuse services, medical 
                        services, and services to address 
                        trauma;</DELETED>
                        <DELETED>    ``(iii) alternatives to 
                        incarceration; and</DELETED>
                        <DELETED>    ``(iv) other appropriate services, 
                        including housing, transportation, mentoring, 
                        employment, job training, education, and 
                        assistance in applying for and obtaining 
                        available benefits.</DELETED>
        <DELETED>    ``(2) Veterans assistance program.--</DELETED>
                <DELETED>    ``(A) In general.--The Attorney General, 
                in consultation with the Secretary of Veterans Affairs, 
                may award grants under this subsection to applicants to 
                establish or expand--</DELETED>
                        <DELETED>    ``(i) veterans treatment court 
                        programs;</DELETED>
                        <DELETED>    ``(ii) peer to peer services or 
                        programs for qualified veterans;</DELETED>
                        <DELETED>    ``(iii) practices that identify 
                        and provide treatment, rehabilitation, legal, 
                        transitional, and other appropriate services to 
                        qualified veterans who have been incarcerated; 
                        and</DELETED>
                        <DELETED>    ``(iv) training programs to teach 
                        criminal justice, law enforcement, corrections, 
                        mental health, and substance abuse personnel 
                        how to identify and appropriately respond to 
                        incidents involving qualified 
                        veterans.</DELETED>
                <DELETED>    ``(B) Priority.--In awarding grants under 
                this subsection, the Attorney General shall give 
                priority to applications that--</DELETED>
                        <DELETED>    ``(i) demonstrate collaboration 
                        between and joint investments by criminal 
                        justice, mental health, substance abuse, and 
                        veterans service agencies;</DELETED>
                        <DELETED>    ``(ii) promote effective 
                        strategies to identify and reduce the risk of 
                        harm to qualified veterans and public safety; 
                        and</DELETED>
                        <DELETED>    ``(iii) propose interventions with 
                        empirical support to improve outcomes for 
                        qualified veterans.''; and</DELETED>
        <DELETED>    (3) in subsection (j), as so redesignated--
        </DELETED>
                <DELETED>    (A) by redesignating paragraph (2) as 
                paragraph (3); and</DELETED>
                <DELETED>    (B) by inserting after paragraph (1) the 
                following:</DELETED>
        <DELETED>    ``(2) Veterans treatment courts.--In addition to 
        the amounts authorized under paragraph (1), there are 
        authorized to be appropriated to the Attorney General 
        $5,000,000 for each of fiscal years 2016 through 2020 to carry 
        out subsection (i).''.</DELETED>

  <DELETED>TITLE VI--INCENTIVIZING STATE COMPREHENSIVE INITIATIVES TO 
               ADDRESS OPIOID AND HEROIN ABUSE</DELETED>

<DELETED>SEC. 601. STATE DEMONSTRATION GRANTS FOR COMPREHENSIVE OPIOID 
              ABUSE RESPONSE.</DELETED>

<DELETED>    Part MM of the Omnibus Crime Control and Safe Streets Act 
of 1968, as amended by section 501, is amended by adding at the end the 
following:</DELETED>

<DELETED>``SEC. 3039. STATE DEMONSTRATION GRANTS FOR COMPREHENSIVE 
              OPIOID ABUSE RESPONSE.</DELETED>

<DELETED>    ``(a) Definitions.--In this section--</DELETED>
        <DELETED>    ``(1) the term `dispenser' has the meaning given 
        the term in section 102 of the Controlled Substances Act (21 
        U.S.C. 802);</DELETED>
        <DELETED>    ``(2) the term `prescriber of a schedule II, III, 
        or IV controlled substance' does not include a prescriber of a 
        schedule II, III, or IV controlled substance that dispenses the 
        substance--</DELETED>
                <DELETED>    ``(A) for use on the premises on which the 
                substance is dispensed;</DELETED>
                <DELETED>    ``(B) in a hospital emergency room, when 
                the substance is in short supply;</DELETED>
                <DELETED>    ``(C) for a certified opioid treatment 
                program; or</DELETED>
                <DELETED>    ``(D) in other situations as the Attorney 
                General may reasonably determine;</DELETED>
        <DELETED>    ``(3) the term `prescriber' means a dispenser who 
        prescribes a controlled substance, or the agent of such a 
        dispenser; and</DELETED>
        <DELETED>    ``(4) the term `schedule II, III, or IV controlled 
        substance' means a controlled substance that is listed on 
        schedule II, schedule III, or schedule IV of section 202(c) of 
        the Controlled Substances Act (21 U.S.C. 812(c)).</DELETED>
<DELETED>    ``(b) Planning and Implementation Grants.--</DELETED>
        <DELETED>    ``(1) In general.--The Attorney General, in 
        coordination with the Secretary of Health and Human Services 
        and the Director of the Office of National Drug Control Policy, 
        may award grants to States, and combinations thereof, to 
        prepare a comprehensive plan for and implement an integrated 
        opioid abuse response initiative.</DELETED>
        <DELETED>    ``(2) Purposes.--A State receiving a grant under 
        this section shall establish a comprehensive response to opioid 
        abuse, which shall include--</DELETED>
                <DELETED>    ``(A) prevention and education efforts 
                around heroin and opioid use, treatment, and 
                recovery;</DELETED>
                <DELETED>    ``(B) a comprehensive prescription drug 
                monitoring program to track dispensing of schedule II, 
                III, or IV controlled substances, which shall include--
                </DELETED>
                        <DELETED>    ``(i) data sharing with other 
                        States by statute, regulation, or interstate 
                        agreement; and</DELETED>
                        <DELETED>    ``(ii) educating physicians, 
                        residents, medical students, and other 
                        prescribers of Schedule II, III, or IV 
                        controlled substances on the prescription drug 
                        monitoring program of the State;</DELETED>
                <DELETED>    ``(C) developing, implementing, or 
                expanding the prescription drug and opioid addiction 
                treatment program of the State by--</DELETED>
                        <DELETED>    ``(i) expanding programs for 
                        medication assisted treatment of prescription 
                        drug and opioid addiction, including training 
                        for treatment and recovery support 
                        providers;</DELETED>
                        <DELETED>    ``(ii) developing, implementing, 
                        or expanding programs for behavioral health 
                        therapy for individuals who are in treatment 
                        for prescription drug and opioid addiction, 
                        including contingency management, cognitive 
                        behavioral therapy, and motivational 
                        enhancements;</DELETED>
                        <DELETED>    ``(iii) developing, implementing, 
                        or expanding programs to screen individuals who 
                        are in treatment for prescription drug and 
                        opioid addiction for hepatitis C and HIV, and 
                        provide treatment for those individuals if 
                        clinically appropriate; or</DELETED>
                        <DELETED>    ``(iv) developing, implementing, 
                        or expanding programs that provide screening, 
                        early intervention, and referral to treatment 
                        (commonly referred to as `SBIRT') to teenagers 
                        and young adults in primary care, middle 
                        schools, high schools, universities, school-
                        based health centers, and other community-based 
                        health care settings frequently accessed by 
                        teenagers or young adults; and</DELETED>
                <DELETED>    ``(D) developing, implementing, and 
                expanding programs to prevent overdose death of 
                prescription medications and opioids.</DELETED>
        <DELETED>    ``(3) Planning grant applications.--</DELETED>
                <DELETED>    ``(A) Application.--</DELETED>
                        <DELETED>    ``(i) In general.--A State 
                        desiring a planning grant under this section to 
                        prepare a comprehensive plan for an integrated 
                        opioid abuse response initiative shall submit 
                        to the Attorney General an application in such 
                        form, and containing such information, as the 
                        Attorney General may prescribe by regulation or 
                        guidelines.</DELETED>
                        <DELETED>    ``(ii) Requirements.--An 
                        application for a planning grant under this 
                        section shall, at a minimum, include--
                        </DELETED>
                                <DELETED>    ``(I) a budget and a 
                                budget justification for the activities 
                                to be carried out using the 
                                grant;</DELETED>
                                <DELETED>    ``(II) a description of 
                                the activities proposed to be carried 
                                out using the grant, including a 
                                schedule for completion of such 
                                activities;</DELETED>
                                <DELETED>    ``(III) outcome measures 
                                that will be used to measure the 
                                effectiveness of the programs and 
                                initiatives to address opioids; 
                                and</DELETED>
                                <DELETED>    ``(IV) a description of 
                                the personnel necessary to complete 
                                such activities.</DELETED>
                <DELETED>    ``(B) Period; nonrenewability.--A planning 
                grant under this section shall be for a period of 1 
                year. A State may not receive more than 1 planning 
                grant under this section.</DELETED>
                <DELETED>    ``(C) Amount.--A planning grant under this 
                section may not exceed $100,000, except that the 
                Attorney General may, for good cause, approve a grant 
                in a higher amount.</DELETED>
                <DELETED>    ``(D) Strategic plan and program 
                implementation plan.--A State receiving a planning 
                grant under this section shall develop a strategic plan 
                and a program implementation plan.</DELETED>
        <DELETED>    ``(4) Implementation grants.--</DELETED>
                <DELETED>    ``(A) Application.--A State desiring an 
                implementation grant under this section to implement a 
                comprehensive strategy for addressing opioid abuse 
                shall submit to the Attorney General an application in 
                such form, and containing such information, as the 
                Attorney General may prescribe by regulation or 
                guidelines.</DELETED>
                <DELETED>    ``(B) Use of funds.--A State that receives 
                an implementation grant under this section shall use 
                the grant for the cost of carrying out an integrated 
                opioid abuse response program in accordance with this 
                section, including for technical assistance, training, 
                and administrative expenses.</DELETED>
                <DELETED>    ``(C) Requirements.--An integrated opioid 
                abuse response program carried out using an 
                implementation grant under this section shall--
                </DELETED>
                        <DELETED>    ``(i) ensure that each prescriber 
                        of a schedule II, III, or IV controlled 
                        substance in the State--</DELETED>
                                <DELETED>    ``(I) registers with the 
                                prescription drug monitoring program of 
                                the State; and</DELETED>
                                <DELETED>    ``(II) consults the 
                                prescription drug monitoring program 
                                database of the State before 
                                prescribing a schedule II, III, or IV 
                                controlled substance;</DELETED>
                        <DELETED>    ``(ii) ensure that each dispenser 
                        of a schedule II, III, or IV controlled 
                        substance in the State--</DELETED>
                                <DELETED>    ``(I) registers with the 
                                prescription drug monitoring program of 
                                the State;</DELETED>
                                <DELETED>    ``(II) consults the 
                                prescription drug monitoring program 
                                database of the State before dispensing 
                                a schedule II, III, or IV controlled 
                                substance; and</DELETED>
                                <DELETED>    ``(III) reports to the 
                                prescription drug monitoring program of 
                                the State, at a minimum, each instance 
                                in which a schedule II, III, or IV 
                                controlled substance is dispensed, with 
                                limited exceptions, as defined by the 
                                State, which shall indicate the 
                                prescriber by name and National 
                                Provider Identifier;</DELETED>
                        <DELETED>    ``(iii) require that, not fewer 
                        than 4 times each year, the State agency or 
                        agencies that administer the prescription drug 
                        monitoring program of the State prepare and 
                        provide to each prescriber of a schedule II, 
                        III, or IV controlled substance an 
                        informational report that shows how the 
                        prescribing patterns of the prescriber compare 
                        to prescribing practices of the peers of the 
                        prescriber and expected norms;</DELETED>
                        <DELETED>    ``(iv) if informational reports 
                        provided to a prescriber under clause (iii) 
                        indicate that the prescriber is repeatedly 
                        falling outside of expected norms or standard 
                        practices for the prescriber's field, direct 
                        the prescriber to educational resources on 
                        appropriate prescribing of controlled 
                        substances;</DELETED>
                        <DELETED>    ``(v) ensure that the prescriber 
                        licensing board of the State receives a report 
                        describing any prescribers that repeatedly fall 
                        outside of expected norms or standard practices 
                        for the prescriber's field, as described in 
                        clause (iii);</DELETED>
                        <DELETED>    ``(vi) require consultation with 
                        the Single State Authority for Substance Abuse; 
                        and</DELETED>
                        <DELETED>    ``(vii) establish requirements for 
                        how data will be collected and analyzed to 
                        determine the effectiveness of the 
                        program.</DELETED>
                <DELETED>    ``(D) Period.--An implementation grant 
                under this section shall be for a period of 2 
                years.</DELETED>
                <DELETED>    ``(E) Amount.--The amount of an 
                implementation grant under this section may not exceed 
                $5,000,000 except that the Attorney General may, for 
                good cause, approve a grant in a higher 
                amount.</DELETED>
        <DELETED>    ``(5) Priority considerations.--In awarding 
        planning and implementation grants under this section, the 
        Attorney General shall give priority to a State that--
        </DELETED>
                <DELETED>    ``(A) provides civil liability protection 
                for first responders, health professionals, and family 
                members administering naloxone to counteract opioid 
                overdoses by--</DELETED>
                        <DELETED>    ``(i) enacting legislation that 
                        provides such civil liability protection; 
                        or</DELETED>
                        <DELETED>    ``(ii) providing a certification 
                        by the attorney general of the State that the 
                        attorney general has--</DELETED>
                                <DELETED>    ``(I) reviewed any 
                                applicable civil liability protection 
                                law to determine the applicability of 
                                the law with respect to first 
                                responders, health care professionals, 
                                family members, and other individuals 
                                who may administer naloxone to 
                                individuals reasonably believed to be 
                                suffering from opioid overdose; 
                                and</DELETED>
                                <DELETED>    ``(II) concluded that the 
                                law described in subclause (I) provides 
                                adequate civil liability protection 
                                applicable to such persons;</DELETED>
                <DELETED>    ``(B) have in effect legislation or 
                implement a policy under which the State shall not 
                terminate, but may suspend, enrollment under the State 
                plan for medical assistance under title XIX of the 
                Social Security Act (42 U.S.C. 1396 et seq.) for an 
                individual who is incarcerated for a period of fewer 
                than 2 years;</DELETED>
                <DELETED>    ``(C) have a process for enrollment in 
                services and benefits necessary by criminal justice 
                agencies to initiate or continue treatment in the 
                community, under which an individual who is 
                incarcerated may, while incarcerated, enroll in 
                services and benefits that are necessary for the 
                individual to continue treatment upon release from 
                incarceration;</DELETED>
                <DELETED>    ``(D) ensures the capability of data 
                sharing with other States, such as by making data 
                available to a prescription monitoring hub;</DELETED>
                <DELETED>    ``(E) ensures that data recorded in the 
                prescription drug monitoring program database of the 
                State is available within 24 hours, to the extent 
                possible; and</DELETED>
                <DELETED>    ``(F) ensures that the prescription drug 
                monitoring program of the State notifies prescribers 
                and dispensers of schedule II, III, or IV controlled 
                substances when overuse or misuse of such controlled 
                substances by patients is suspected.</DELETED>
<DELETED>    ``(c) Authorization of Appropriations.--There are 
authorized to be appropriated to carry out this section $15,000,000 for 
each of fiscal years 2016 through 2020.''.</DELETED>

            <DELETED>TITLE VII--OFFSET; GAO REPORT</DELETED>

<DELETED>SEC. 701. OFFSET.</DELETED>

<DELETED>    It is the sense of Congress that the amounts expended to 
carry out this Act and the amendments made by this Act should be offset 
by a corresponding reduction in Federal non-defense discretionary 
spending.</DELETED>

<DELETED>SEC. 702. GAO REPORT ON IMD EXCLUSION.</DELETED>

<DELETED>    (a) Definition.--In this section, the term ``Medicaid 
Institutions for Mental Disease exclusion'' means the prohibition on 
Federal matching payments under Medicaid for patients who have attained 
age 22, but have not attained age 65, in an institution for mental 
diseases under subparagraph (B) of the matter following subsection (a) 
of section 1905 of the Social Security Act and subsection (i) of such 
section (42 U.S.C. 1396d).</DELETED>
<DELETED>    (b) Report Required.--Not later than 180 days after the 
date of enactment of this Act, the Comptroller General of the United 
States shall submit to Congress a report on the impact that the 
Medicaid Institutions for Mental Disease exclusion has on access to 
treatment for individuals with a substance use disorder.</DELETED>
<DELETED>    (c) Elements.--The report required under subsection (b) 
shall include the following:</DELETED>
        <DELETED>    (1) An analysis of whether the following policy 
        changes to the Medicaid Institutions for Mental Disease 
        exclusion would enhance access to treatment for individuals 
        with a substance use disorder:</DELETED>
                <DELETED>    (A) Removing substance use disorder 
                treatment and facilities from the Medicaid Institutions 
                for Mental Disease exclusion.</DELETED>
                <DELETED>    (B) Amending section 1905(i) of the Social 
                Security Act (42 U.S.C. 1396d(i)) to modestly raise the 
                16-bed limit in the definition of an institution for 
                mental diseases under that section.</DELETED>
                <DELETED>    (C) Repealing the Medicaid Institutions 
                for Mental Disease exclusion.</DELETED>
        <DELETED>    (2) An analysis of whether and to what extent the 
        quality of care for substance use disorder treatment is 
        impacted by the Medicaid Institutions for Mental Disease 
        exclusion.</DELETED>
        <DELETED>    (3) An analysis of barriers in accessing State-
        specific information related to the impact of the Medicaid 
        Institutions for Mental Disease exclusion on access to 
        treatment.</DELETED>
        <DELETED>    (4) An analysis of the difference in cost between 
        treatment for a substance use disorder in a hospital setting 
        compared to a community-based care setting.</DELETED>
        <DELETED>    (5) An analysis of the characteristics of 
        institutions for mental diseases (as defined in section 1905(i) 
        of the Social Security Act (42 U.S.C. 1396d(i))), including the 
        patient capacity of such institutions as well as the type of 
        care setting, among other characteristics.</DELETED>

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Comprehensive 
Addiction and Recovery Act of 2016''.
    (b) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title; table of contents.
Sec. 2. Findings.
Sec. 3. Definitions.

                   TITLE I--PREVENTION AND EDUCATION

Sec. 101. Development of best practices for the use of prescription 
                            opioids.
Sec. 102. Awareness campaigns.
Sec. 103. Community-based coalition enhancement grants to address local 
                            drug crises.

                TITLE II--LAW ENFORCEMENT AND TREATMENT

Sec. 201. Treatment alternative to incarceration programs.
Sec. 202. First responder training for the use of drugs and devices 
                            that rapidly reverse the effects of 
                            opioids.
Sec. 203. Prescription drug take back expansion.
Sec. 204. Heroin and methamphetamine task forces.

                   TITLE III--TREATMENT AND RECOVERY

Sec. 301. Evidence-based opioid and heroin treatment and interventions 
                            demonstration.
Sec. 302. Criminal justice medication assisted treatment and 
                            interventions demonstration.
Sec. 303. National youth recovery initiative.
Sec. 304. Building communities of recovery.

              TITLE IV--ADDRESSING COLLATERAL CONSEQUENCES

Sec. 401. Correctional education demonstration grant program.
Sec. 402. National Task Force on Recovery and Collateral Consequences.

  TITLE V--ADDICTION AND TREATMENT SERVICES FOR WOMEN, FAMILIES, AND 
                                VETERANS

Sec. 501. Improving treatment for pregnant and postpartum women.
Sec. 502. Report on grants for family-based substance abuse treatment.
Sec. 503. Veterans' treatment courts.

  TITLE VI--INCENTIVIZING STATE COMPREHENSIVE INITIATIVES TO ADDRESS 
                        OPIOID AND HEROIN ABUSE

Sec. 601. State demonstration grants for comprehensive opioid abuse 
                            response.

                        TITLE VII--MISCELLANEOUS

Sec. 701. GAO report on IMD exclusion.
Sec. 702. Funding.
Sec. 703. Conforming amendments.
Sec. 704. Grant accountability.

SEC. 2. FINDINGS.

    Congress finds the following:
            (1) The abuse of heroin and prescription opioid painkillers 
        is having a devastating effect on public health and safety in 
        communities across the United States. According to the Centers 
        for Disease Control and Prevention, drug overdose deaths now 
        surpass traffic crashes in the number of deaths caused by 
        injury in the United States. In 2014, an average of more than 
        120 people in the United States died from drug overdoses every 
        day.
            (2) According to the National Institute on Drug Abuse 
        (commonly known as ``NIDA''), the number of prescriptions for 
        opioids increased from approximately 76,000,000 in 1991 to 
        nearly 207,000,000 in 2013, and the United States is the 
        biggest consumer of opioids globally, accounting for almost 100 
        percent of the world total for hydrocodone and 81 percent for 
        oxycodone.
            (3) Opioid pain relievers are the most widely misused or 
        abused controlled prescription drugs (commonly referred to as 
        ``CPDs'') and are involved in most CPD-related overdose 
        incidents. According to the Drug Abuse Warning Network 
        (commonly known as ``DAWN''), the estimated number of emergency 
        department visits involving nonmedical use of prescription 
        opiates or opioids increased by 112 percent between 2006 and 
        2010, from 84,671 to 179,787.
            (4) The use of heroin in the United States has also spiked 
        sharply in recent years. According to the most recent National 
        Survey on Drug Use and Health, more than 900,000 people in the 
        United States reported using heroin in 2014, nearly a 35 
        percent increase from the previous year. Heroin overdose deaths 
        more than tripled from 2010 to 2014.
            (5) The supply of cheap heroin available in the United 
        States has increased dramatically as well, largely due to the 
        activity of Mexican drug trafficking organizations. The Drug 
        Enforcement Administration (commonly known as the ``DEA'') 
        estimates that heroin seizures at the Mexican border have more 
        than doubled since 2010, and heroin production in Mexico 
        increased 62 percent from 2013 to 2014. While only 8 percent of 
        State and local law enforcement officials across the United 
        States identified heroin as the greatest drug threat in their 
        area in 2008, that number rose to 38 percent in 2015.
            (6) Law enforcement officials and treatment experts 
        throughout the country report that many prescription opioid 
        users have turned to heroin as a cheaper or more easily 
        obtained alternative to prescription drugs.
            (7) According to a report by the National Association of 
        State Alcohol and Drug Abuse Directors (commonly referred to as 
        ``NASADAD''), 37 States reported an increase in admissions to 
        treatment for heroin use during the past 2 years, while 
        admissions to treatment for prescription opiates increased 500 
        percent from 2000 to 2012.
            (8) Research indicates that combating the opioid crisis, 
        including abuse of prescription painkillers and, increasingly, 
        heroin, requires a multi-pronged approach that involves 
        prevention, education, monitoring, law enforcement initiatives, 
        reducing drug diversion and the supply of illicit drugs, 
        expanding delivery of existing treatments (including medication 
        assisted treatments), expanding access to overdose medications 
        and interventions, and the development of new medications for 
        pain that can augment the existing treatment arsenal.
            (9) Substance use disorders are a treatable disease. 
        Discoveries in the science of addiction have led to advances in 
        the treatment of substance use disorders that help people stop 
        abusing drugs and prescription medications and resume their 
        productive lives.
            (10) According to the National Survey on Drug Use and 
        Health, approximately 22,700,000 people in the United States 
        needed substance use disorder treatment in 2013, but only 
        2,500,000 people received it. Furthermore, current treatment 
        services are not adequate to meet demand. According to a report 
        commissioned by the Substance Abuse and Mental Health Services 
        Administration (commonly known as ``SAMHSA''), there are 
        approximately 32 providers for every 1,000 individuals needing 
        substance use disorder treatment. In some States, the ratio is 
        much lower.
            (11) The overall cost of drug abuse, from health care- and 
        criminal justice-related costs to lost productivity, is steep, 
        totaling more than $700,000,000,000 a year, according to NIDA. 
        Effective substance abuse prevention can yield major economic 
        dividends.
            (12) According to NIDA, when schools and communities 
        properly implement science-validated substance abuse prevention 
        programs, abuse of alcohol, tobacco, and illicit drugs is 
        reduced. Such programs help teachers, parents, and healthcare 
        professionals shape the perceptions of youths about the risks 
        of drug abuse.
            (13) Diverting certain individuals with substance use 
        disorders from criminal justice systems into community-based 
        treatment can save billions of dollars and prevent sizeable 
        numbers of crimes, arrests, and re-incarcerations over the 
        course of those individuals' lives.
            (14) According to the DEA, more than 2,700 tons of expired, 
        unwanted prescription medications have been collected since the 
        enactment of the Secure and Responsible Drug Disposal Act of 
        2010 (Public Law 111-273; 124 Stat. 2858).
            (15) Faith-based, holistic, or drug-free models can provide 
        a critical path to successful recovery for a great number of 
        people in the United States. The 2015 membership survey 
        conducted by Alcoholics Anonymous (commonly known as ``AA'') 
        found that 73 percent of AA members were sober longer than 1 
        year and attended 2.5 meetings per week.
            (16) Research shows that combining treatment medications 
        with behavioral therapy is an effective way to facilitate 
        success for some patients. Treatment approaches must be 
        tailored to address the drug abuse patterns and drug-related 
        medical, psychiatric, and social problems of each individual. 
        Different types of medications may be useful at different 
        stages of treatment or recovery to help a patient stop using 
        drugs, stay in treatment, and avoid relapse. Patients have a 
        range of options regarding their path to recovery and many have 
        also successfully addressed drug abuse through the use of 
        faith-based, holistic, or drug-free models.
            (17) Individuals with mental illness, especially severe 
        mental illness, are at considerably higher risk for substance 
        abuse than the general population, and the presence of a mental 
        illness complicates recovery from substance abuse.

SEC. 3. DEFINITIONS.

    In this Act--
            (1) the term ``medication assisted treatment'' means the 
        use, for problems relating to heroin and other opioids, of 
        medications approved by the Food and Drug Administration in 
        combination with counseling and behavioral therapies;
            (2) the term ``opioid'' means any drug having an addiction-
        forming or addiction-sustaining liability similar to morphine 
        or being capable of conversion into a drug having such 
        addiction-forming or addiction-sustaining liability; and
            (3) the term ``State'' means any State of the United 
        States, the District of Columbia, the Commonwealth of Puerto 
        Rico, and any territory or possession of the United States.

                   TITLE I--PREVENTION AND EDUCATION

SEC. 101. DEVELOPMENT OF BEST PRACTICES FOR THE USE OF PRESCRIPTION 
              OPIOIDS.

    (a) Definitions.--In this section--
            (1) the term ``Secretary'' means the Secretary of Health 
        and Human Services; and
            (2) the term ``task force'' means the Pain Management Best 
        Practices Inter-Agency Task Force convened under subsection 
        (b).
    (b) Inter-Agency Task Force.--Not later than December 14, 2018, the 
Secretary, in cooperation with the Secretary of Veterans Affairs, the 
Secretary of Defense, and the Administrator of the Drug Enforcement 
Administration, shall convene a Pain Management Best Practices Inter-
Agency Task Force to review, modify, and update, as appropriate, best 
practices for pain management (including chronic and acute pain) and 
prescribing pain medication.
    (c) Membership.--The task force shall be comprised of--
            (1) representatives of--
                    (A) the Department of Health and Human Services;
                    (B) the Department of Veterans Affairs;
                    (C) the Food and Drug Administration;
                    (D) the Department of Defense;
                    (E) the Drug Enforcement Administration;
                    (F) the Centers for Disease Control and Prevention;
                    (G) the National Academy of Medicine;
                    (H) the National Institutes of Health; and
                    (I) the Office of National Drug Control Policy;
            (2) physicians, dentists, and non-physician prescribers;
            (3) pharmacists;
            (4) experts in the fields of pain research and addiction 
        research;
            (5) representatives of--
                    (A) pain management professional organizations;
                    (B) the mental health treatment community;
                    (C) the addiction treatment community;
                    (D) pain advocacy groups; and
                    (E) groups with expertise around overdose reversal; 
                and
            (6) other stakeholders, as the Secretary determines 
        appropriate.
    (d) Duties.--The task force shall--
            (1) not later than 180 days after the date on which the 
        task force is convened under subsection (b), review, modify, 
        and update, as appropriate, best practices for pain management 
        (including chronic and acute pain) and prescribing pain 
        medication, taking into consideration--
                    (A) existing pain management research;
                    (B) recommendations from relevant conferences;
                    (C) ongoing efforts at the State and local levels 
                and by medical professional organizations to develop 
                improved pain management strategies, including 
                consideration of alternatives to opioids to reduce 
                opioid monotherapy in appropriate cases;
                    (D) the management of high-risk populations, other 
                than populations who suffer pain, who--
                            (i) may use or be prescribed 
                        benzodiazepines, alcohol, and diverted opioids; 
                        or
                            (ii) receive opioids in the course of 
                        medical care; and
                    (E) the Proposed 2016 Guideline for Prescribing 
                Opioids for Chronic Pain issued by the Centers for 
                Disease Control and Prevention (80 Fed. Reg. 77351 
                (December 14, 2015)) and any final guidelines issued by 
                the Centers for Disease Control and Prevention;
            (2) solicit and take into consideration public comment on 
        the practices developed under paragraph (1), amending such best 
        practices if appropriate; and
            (3) develop a strategy for disseminating information about 
        the best practices to stakeholders, as appropriate.
    (e) Limitation.--The task force shall not have rulemaking 
authority.
    (f) Report.--Not later than 270 days after the date on which the 
task force is convened under subsection (b), the task force shall 
submit to Congress a report that includes--
            (1) the strategy for disseminating best practices for pain 
        management (including chronic and acute pain) and prescribing 
        pain medication, as reviewed, modified, or updated under 
        subsection (d);
            (2) the results of a feasibility study on linking the best 
        practices described in paragraph (1) to receiving and renewing 
        registrations under section 303(f) of the Controlled Substances 
        Act (21 U.S.C. 823(f)); and
            (3) recommendations for effectively applying the best 
        practices described in paragraph (1) to improve prescribing 
        practices at medical facilities, including medical facilities 
        of the Veterans Health Administration.

SEC. 102. AWARENESS CAMPAIGNS.

    (a) In General.--The Secretary of Health and Human Services, in 
coordination with the Attorney General, shall advance the education and 
awareness of the public, providers, patients, and other appropriate 
entities regarding the risk of abuse of prescription opioid drugs if 
such products are not taken as prescribed.
    (b) Drug-Free Media Campaign.--
            (1) In general.--The Office of National Drug Control 
        Policy, in coordination with the Secretary of Health and Human 
        Services and the Attorney General, shall establish a national 
        drug awareness campaign.
            (2) Requirements.--The national drug awareness campaign 
        required under paragraph (1) shall--
                    (A) take into account the association between 
                prescription opioid abuse and heroin use;
                    (B) emphasize the similarities between heroin and 
                prescription opioids and the effects of heroin and 
                prescription opioids on the human body; and
                    (C) bring greater public awareness to the dangerous 
                effects of fentanyl when mixed with heroin or abused in 
                a similar manner.

SEC. 103. COMMUNITY-BASED COALITION ENHANCEMENT GRANTS TO ADDRESS LOCAL 
              DRUG CRISES.

    Part II of title I of the Omnibus Crime Control and Safe Streets 
Act of 1968 (42 U.S.C. 3797cc et seq.) is amended by striking section 
2997 and inserting the following:

``SEC. 2997. COMMUNITY-BASED COALITION ENHANCEMENT GRANTS TO ADDRESS 
              LOCAL DRUG CRISES.

    ``(a) Definitions.--In this section--
            ``(1) the term `Drug-Free Communities Act of 1997' means 
        chapter 2 of the National Narcotics Leadership Act of 1988 (21 
        U.S.C. 1521 et seq.);
            ``(2) the term `eligible entity' means an organization 
        that--
                    ``(A) on or before the date of submitting an 
                application for a grant under this section, receives or 
                has received a grant under the Drug-Free Communities 
                Act of 1997; and
                    ``(B) has documented, using local data, rates of 
                abuse of opioids or methamphetamines at levels that 
                are--
                            ``(i) significantly higher than the 
                        national average as determined by the Attorney 
                        General (including appropriate consideration of 
                        the results of the Monitoring the Future Survey 
                        published by the National Institute on Drug 
                        Abuse and the National Survey on Drug Use and 
                        Health published by the Substance Abuse and 
                        Mental Health Services Administration); or
                            ``(ii) higher than the national average, as 
                        determined by the Attorney General (including 
                        appropriate consideration of the results of the 
                        surveys described in clause (i)), over a 
                        sustained period of time; and
            ``(3) the term `local drug crisis' means, with respect to 
        the area served by an eligible entity--
                    ``(A) a sudden increase in the abuse of opioids or 
                methamphetamines, as documented by local data; or
                    ``(B) the abuse of prescription medications, 
                specifically opioids or methamphetamines, that is 
                significantly higher than the national average, over a 
                sustained period of time, as documented by local data.
    ``(b) Program Authorized.--The Attorney General, in coordination 
with the Director of the Office of National Drug Control Policy, may 
make grants to eligible entities to implement comprehensive community-
wide strategies that address local drug crises within the area served 
by the eligible entity.
    ``(c) Application.--
            ``(1) In general.--An eligible entity seeking a grant under 
        this section shall submit an application to the Attorney 
        General at such time, in such manner, and accompanied by such 
        information as the Attorney General may require.
            ``(2) Criteria.--As part of an application for a grant 
        under this section, the Attorney General shall require an 
        eligible entity to submit a detailed, comprehensive, multi-
        sector plan for addressing the local drug crisis within the 
        area served by the eligible entity.
    ``(d) Use of Funds.--An eligible entity shall use a grant received 
under this section--
            ``(1) for programs designed to implement comprehensive 
        community-wide prevention strategies to address the local drug 
        crisis in the area served by the eligible entity, in accordance 
        with the plan submitted under subsection (c)(2); and
            ``(2) to obtain specialized training and technical 
        assistance from the organization funded under section 4 of 
        Public Law 107-82 (21 U.S.C. 1521 note).
    ``(e) Supplement Not Supplant.--An eligible entity shall use 
Federal funds received under this section only to supplement the funds 
that would, in the absence of those Federal funds, be made available 
from other Federal and non-Federal sources for the activities described 
in this section, and not to supplant those funds.
    ``(f) Evaluation.--A grant under this section shall be subject to 
the same evaluation requirements and procedures as the evaluation 
requirements and procedures imposed on the recipient of a grant under 
the Drug-Free Communities Act of 1997.
    ``(g) Limitation on Administrative Expenses.--Not more than 8 
percent of the amounts made available pursuant to subsection (i) for a 
fiscal year may be used by the Attorney General to pay for 
administrative expenses.''.

                TITLE II--LAW ENFORCEMENT AND TREATMENT

SEC. 201. TREATMENT ALTERNATIVE TO INCARCERATION PROGRAMS.

    (a) Definitions.--In this section:
            (1) Eligible entity.--The term ``eligible entity'' means a 
        State, unit of local government, Indian tribe, or nonprofit 
        organization.
            (2) Eligible participant.--The term ``eligible 
        participant'' means an individual who--
                    (A) comes into contact with the juvenile justice 
                system or criminal justice system or is arrested or 
                charged with an offense that is not--
                            (i) a crime of violence, as defined under 
                        applicable State law or section 16 of title 18, 
                        United States Code; or
                            (ii) a serious drug offense, as defined 
                        under section 924(e)(2)(A) of title 18, United 
                        States Code;
                    (B) has a current--
                            (i) substance use disorder; or
                            (ii) co-occurring mental illness and 
                        substance use disorder; and
                    (C) has been approved for participation in a 
                program funded under this section by, as applicable 
                depending on the stage of the criminal justice process, 
                the relevant law enforcement agency or prosecuting 
                attorney, defense attorney, probation or corrections 
                official, judge, or representative from the relevant 
                mental health or substance abuse agency.
    (b) Program Authorized.--The Secretary of Health and Human 
Services, in coordination with the Attorney General, may make grants to 
eligible entities to--
            (1) develop, implement, or expand a treatment alternative 
        to incarceration program for eligible participants, including--
                    (A) pre-booking, including pre-arrest, treatment 
                alternative to incarceration programs, including--
                            (i) law enforcement training on substance 
                        use disorders and co-occurring mental illness 
                        and substance use disorders;
                            (ii) receiving centers as alternatives to 
                        incarceration of eligible participants;
                            (iii) specialized response units for calls 
                        related to substance use disorders and co-
                        occurring mental illness and substance use 
                        disorders; and
                            (iv) other pre-arrest or pre-booking 
                        treatment alternative to incarceration models; 
                        and
                    (B) post-booking treatment alternative to 
                incarceration programs, including--
                            (i) specialized clinical case management;
                            (ii) pre-trial services related to 
                        substance use disorders and co-occurring mental 
                        illness and substance use disorders;
                            (iii) prosecutor and defender based 
                        programs;
                            (iv) specialized probation;
                            (v) programs utilizing the American Society 
                        of Addiction Medicine patient placement 
                        criteria;
                            (vi) treatment and rehabilitation programs 
                        and recovery support services; and
                            (vii) drug courts, DWI courts, and veterans 
                        treatment courts; and
            (2) facilitate or enhance planning and collaboration 
        between State criminal justice systems and State substance 
        abuse systems in order to more efficiently and effectively 
        carry out programs described in paragraph (1) that address 
        problems related to the use of heroin and misuse of 
        prescription drugs among eligible participants.
    (c) Application.--
            (1) In general.--An eligible entity desiring a grant under 
        this section shall submit an application to the Secretary of 
        Health and Human Services--
                    (A) that meets the criteria under paragraph (2); 
                and
                    (B) at such time, in such manner, and accompanied 
                by such information as the Secretary of Health and 
                Human Services may require.
            (2) Criteria.--An eligible entity, in submitting an 
        application under paragraph (1), shall--
                    (A) provide extensive evidence of collaboration 
                with State and local government agencies overseeing 
                health, community corrections, courts, prosecution, 
                substance abuse, mental health, victims services, and 
                employment services, and with local law enforcement 
                agencies;
                    (B) demonstrate consultation with the Single State 
                Authority for Substance Abuse;
                    (C) demonstrate consultation with the Single State 
                criminal justice planning agency;
                    (D) demonstrate that evidence-based treatment 
                practices, including if applicable the use of 
                medication assisted treatment, will be utilized; and
                    (E) demonstrate that evidenced-based screening and 
                assessment tools will be utilized to place participants 
                in the treatment alternative to incarceration program.
    (d) Requirements.--Each eligible entity awarded a grant for a 
treatment alternative to incarceration program under this section 
shall--
            (1) determine the terms and conditions of participation in 
        the program by eligible participants, taking into consideration 
        the collateral consequences of an arrest, prosecution, or 
        criminal conviction;
            (2) ensure that each substance abuse and mental health 
        treatment component is licensed and qualified by the relevant 
        jurisdiction;
            (3) for programs described in subsection (b)(2), organize 
        an enforcement unit comprised of appropriately trained law 
        enforcement professionals under the supervision of the State, 
        tribal, or local criminal justice agency involved, the duties 
        of which shall include--
                    (A) the verification of addresses and other 
                contacts of each eligible participant who participates 
                or desires to participate in the program; and
                    (B) if necessary, the location, apprehension, 
                arrest, and return to court of an eligible participant 
                in the program who has absconded from the facility of a 
                treatment provider or has otherwise violated the terms 
                and conditions of the program, consistent with Federal 
                and State confidentiality requirements;
            (4) notify the relevant criminal justice entity if any 
        eligible participant in the program absconds from the facility 
        of the treatment provider or otherwise violates the terms and 
        conditions of the program, consistent with Federal and State 
        confidentiality requirements;
            (5) submit periodic reports on the progress of treatment or 
        other measured outcomes from participation in the program of 
        each eligible participant in the program to the relevant State, 
        tribal, or local criminal justice agency;
            (6) describe the evidence-based methodology and outcome 
        measurements that will be used to evaluate the program, and 
        specifically explain how such measurements will provide valid 
        measures of the impact of the program; and
            (7) describe how the program could be broadly replicated if 
        demonstrated to be effective.
    (e) Use of Funds.--An eligible entity shall use a grant received 
under this section for expenses of a treatment alternative to 
incarceration program, including--
            (1) salaries, personnel costs, equipment costs, and other 
        costs directly related to the operation of the program, 
        including the enforcement unit;
            (2) payments for treatment providers that are approved by 
        the relevant State or tribal jurisdiction and licensed, if 
        necessary, to provide needed treatment to eligible participants 
        in the program, including medication assisted treatment, 
        aftercare supervision, vocational training, education, and job 
        placement;
            (3) payments to public and nonprofit private entities that 
        are approved by the State or tribal jurisdiction and licensed, 
        if necessary, to provide alcohol and drug addiction treatment 
        and mental health treatment to eligible participants in the 
        program; and
            (4) salaries, personnel costs, and other costs related to 
        strategic planning among State and local government agencies.
    (f) Supplement Not Supplant.--An eligible entity shall use Federal 
funds received under this section only to supplement the funds that 
would, in the absence of those Federal funds, be made available from 
other Federal and non-Federal sources for the activities described in 
this section, and not to supplant those funds.
    (g) Geographic Distribution.--The Secretary of Health and Human 
Services shall ensure that, to the extent practicable, the geographical 
distribution of grants under this section is equitable and includes a 
grant to an eligible entity in--
            (1) each State;
            (2) rural, suburban, and urban areas; and
            (3) tribal jurisdictions.
    (h) Priority Consideration With Respect to States.--In awarding 
grants to States under this section, the Secretary of Health and Human 
Services shall give priority to--
            (1) a State that submits a joint application from the 
        substance abuse agencies and criminal justice agencies of the 
        State that proposes to use grant funds to facilitate or enhance 
        planning and collaboration between the agencies, including 
        coordination to better address the needs of incarcerated 
        populations; and
            (2) a State that--
                    (A) provides civil liability protection for first 
                responders, health professionals, and family members 
                who have received appropriate training in the 
                administration of naloxone in administering naloxone to 
                counteract opioid overdoses; and
                    (B) submits to the Secretary a certification by the 
                attorney general of the State that the attorney general 
                has--
                            (i) reviewed any applicable civil liability 
                        protection law to determine the applicability 
                        of the law with respect to first responders, 
                        health care professionals, family members, and 
                        other individuals who--
                                    (I) have received appropriate 
                                training in the administration of 
                                naloxone; and
                                    (II) may administer naloxone to 
                                individuals reasonably believed to be 
                                suffering from opioid overdose; and
                            (ii) concluded that the law described in 
                        subparagraph (A) provides adequate civil 
                        liability protection applicable to such 
                        persons.
    (i) Reports and Evaluations.--
            (1) In general.--Each fiscal year, each recipient of a 
        grant under this section during that fiscal year shall submit 
        to the Secretary of Health and Human Services a report on the 
        outcomes of activities carried out using that grant in such 
        form, containing such information, and on such dates as the 
        Secretary of Health and Human Services shall specify.
            (2) Contents.--A report submitted under paragraph (1) 
        shall--
                    (A) describe best practices for treatment 
                alternatives; and
                    (B) identify training requirements for law 
                enforcement officers who participate in treatment 
                alternative to incarceration programs.
    (j) Funding.--During the 5-year period beginning on the date of 
enactment of this Act, the Secretary of Health and Human Services shall 
carry out this section using funds made available to the Substance 
Abuse and Mental Health Services Administration for Criminal Justice 
Activities.

SEC. 202. FIRST RESPONDER TRAINING FOR THE USE OF DRUGS AND DEVICES 
              THAT RAPIDLY REVERSE THE EFFECTS OF OPIOIDS.

    Part II of title I of the Omnibus Crime Control and Safe Streets 
Act of 1968 (42 U.S.C. 3797cc et seq.), as amended by section 103, is 
amended by adding at the end the following:

``SEC. 2998. FIRST RESPONDER TRAINING FOR THE USE OF DRUGS AND DEVICES 
              THAT RAPIDLY REVERSE THE EFFECTS OF OPIOIDS.

    ``(a) Definition.--In this section--
            ``(1) the terms `drug' and `device' have the meanings given 
        those terms in section 201 of the Federal Food, Drug, and 
        Cosmetic Act (21 U.S.C. 321);
            ``(2) the term `eligible entity' means a State, a unit of 
        local government, or an Indian tribal government;
            ``(3) the term `first responder' includes a firefighter, 
        law enforcement officer, paramedic, emergency medical 
        technician, or other individual (including an employee of a 
        legally organized and recognized volunteer organization, 
        whether compensated or not), who, in the course of professional 
        duties, responds to fire, medical, hazardous material, or other 
        similar emergencies; and
            ``(4) the term `Secretary' means the Secretary of Health 
        and Human Services.
    ``(b) Program Authorized.--The Secretary, in coordination with the 
Attorney General, may make grants to eligible entities to allow 
appropriately trained first responders to administer an opioid overdose 
reversal drug to an individual who has--
            ``(1) experienced a prescription opioid or heroin overdose; 
        or
            ``(2) been determined to have likely experienced a 
        prescription opioid or heroin overdose.
    ``(c) Application.--
            ``(1) In general.--An eligible entity seeking a grant under 
        this section shall submit an application to the Secretary--
                    ``(A) that meets the criteria under paragraph (2); 
                and
                    ``(B) at such time, in such manner, and accompanied 
                by such information as the Secretary may require.
            ``(2) Criteria.--An eligible entity, in submitting an 
        application under paragraph (1), shall--
                    ``(A) describe the evidence-based methodology and 
                outcome measurements that will be used to evaluate the 
                program funded with a grant under this section, and 
                specifically explain how such measurements will provide 
                valid measures of the impact of the program;
                    ``(B) describe how the program could be broadly 
                replicated if demonstrated to be effective;
                    ``(C) identify the governmental and community 
                agencies that the program will coordinate; and
                    ``(D) describe how law enforcement agencies will 
                coordinate with their corresponding State substance 
                abuse and mental health agencies to identify protocols 
                and resources that are available to victims and 
                families, including information on treatment and 
                recovery resources.
    ``(d) Use of Funds.--An eligible entity shall use a grant received 
under this section to--
            ``(1) make such opioid overdose reversal drugs or devices 
        that are approved by the Food and Drug Administration, such as 
        naloxone, available to be carried and administered by first 
        responders;
            ``(2) train and provide resources for first responders on 
        carrying an opioid overdose reversal drug or device approved by 
        the Food and Drug Administration, such as naloxone, and 
        administering the drug or device to an individual who has 
        experienced, or has been determined to have likely experienced, 
        a prescription opioid or heroin overdose; and
            ``(3) establish processes, protocols, and mechanisms for 
        referral to appropriate treatment.
    ``(e) Technical Assistance Grants.--The Secretary shall make a 
grant for the purpose of providing technical assistance and training on 
the use of an opioid overdose reversal drug, such as naloxone, to 
respond to an individual who has experienced, or has been determined to 
have likely experienced, a prescription opioid or heroin overdose, and 
mechanisms for referral to appropriate treatment for an eligible entity 
receiving a grant under this section.
    ``(f) Evaluation.--The Secretary shall conduct an evaluation of 
grants made under this section to determine--
            ``(1) the number of first responders equipped with 
        naloxone, or another opioid overdose reversal drug, for the 
        prevention of fatal opioid and heroin overdose;
            ``(2) the number of opioid and heroin overdoses reversed by 
        first responders receiving training and supplies of naloxone, 
        or another opioid overdose reversal drug, through a grant 
        received under this section;
            ``(3) the number of calls for service related to opioid and 
        heroin overdose;
            ``(4) the extent to which overdose victims and families 
        receive information about treatment services and available data 
        describing treatment admissions; and
            ``(5) the research, training, and naloxone, or another 
        opioid overdose reversal drug, supply needs of first responder 
        agencies, including those agencies that are not receiving 
        grants under this section.
    ``(g) Rural Areas With Limited Access to Emergency Medical 
Services.--In making grants under this section, the Secretary shall 
ensure that not less than 25 percent of grant funds are awarded to 
eligible entities that are not located in metropolitan statistical 
areas, as defined by the Office of Management and Budget.''.

SEC. 203. PRESCRIPTION DRUG TAKE BACK EXPANSION.

    (a) Definition of Covered Entity.--In this section, the term 
``covered entity'' means--
            (1) a State, local, or tribal law enforcement agency;
            (2) a manufacturer, distributor, or reverse distributor of 
        prescription medications;
            (3) a retail pharmacy;
            (4) a registered narcotic treatment program;
            (5) a hospital or clinic with an on-site pharmacy;
            (6) an eligible long-term care facility; or
            (7) any other entity authorized by the Drug Enforcement 
        Administration to dispose of prescription medications.
    (b) Program Authorized.--The Attorney General, in coordination with 
the Administrator of the Drug Enforcement Administration, the Secretary 
of Health and Human Services, and the Director of the Office of 
National Drug Control Policy, shall coordinate with covered entities in 
expanding or making available disposal sites for unwanted prescription 
medications.

SEC. 204. HEROIN AND METHAMPHETAMINE TASK FORCES.

    Part II of title I of the Omnibus Crime Control and Safe Streets 
Act of 1968 (42 U.S.C. 3797cc et seq.), as amended by section 202, is 
amended by adding at the end the following:

``SEC. 2999. HEROIN AND METHAMPHETAMINE TASK FORCES.

    ``The Attorney General may make grants to State law enforcement 
agencies for investigative purposes--
            ``(1) to locate or investigate illicit activities through 
        statewide collaboration, including activities related to--
                    ``(A) the distribution of heroin or fentanyl, or 
                the unlawful distribution of prescription opioids; or
                    ``(B) unlawful heroin, fentanyl, and prescription 
                opioid traffickers; and
            ``(2) to locate or investigate illicit activities, 
        including precursor diversion, laboratories, or methamphetamine 
        traffickers.''.

                   TITLE III--TREATMENT AND RECOVERY

SEC. 301. EVIDENCE-BASED OPIOID AND HEROIN TREATMENT AND INTERVENTIONS 
              DEMONSTRATION.

    Part II of title I of the Omnibus Crime Control and Safe Streets 
Act of 1968 (42 U.S.C. 3797cc et seq.), as amended by section 204, is 
amended by adding at the end the following:

``SEC. 2999A. EVIDENCE-BASED OPIOID AND HEROIN TREATMENT AND 
              INTERVENTIONS DEMONSTRATION.

    ``(a) Definitions.--In this section--
            ``(1) the terms `Indian tribe' and `tribal organization' 
        have the meaning given those terms in section 4 of the Indian 
        Health Care Improvement Act (25 U.S.C. 1603));
            ``(2) the term `medication assisted treatment' means the 
        use, for problems relating to heroin and other opioids, of 
        medications approved by the Food and Drug Administration in 
        combination with counseling and behavioral therapies;
            ``(3) the term `Secretary' means the Secretary of Health 
        and Human Services; and
            ``(4) the term `State substance abuse agency' means the 
        agency of a State responsible for the State prevention, 
        treatment, and recovery system, including management of the 
        Substance Abuse Prevention and Treatment Block Grant under 
        subpart II of part B of title XIX of the Public Health Service 
        Act (42 U.S.C. 300x-21 et seq.).
    ``(b) Grants.--
            ``(1) Authority to make grants.--The Secretary, acting 
        through the Director of the Center for Substance Abuse 
        Treatment of the Substance Abuse and Mental Health Services 
        Administration, and in coordination with the Attorney General 
        and other departments or agencies, as appropriate, may award 
        grants to State substance abuse agencies, units of local 
        government, nonprofit organizations, and Indian tribes or 
        tribal organizations that have a high rate, or have had a rapid 
        increase, in the use of heroin or other opioids, in order to 
        permit such entities to expand activities, including an 
        expansion in the availability of medication assisted treatment 
        and other clinically appropriate services, with respect to the 
        treatment of addiction in the specific geographical areas of 
        such entities where there is a high rate or rapid increase in 
        the use of heroin or other opioids.
            ``(2) Nature of activities.--The grant funds awarded under 
        paragraph (1) shall be used for activities that are based on 
        reliable scientific evidence of efficacy in the treatment of 
        problems related to heroin or other opioids.
    ``(c) Geographic Distribution.--The Secretary shall ensure that 
grants awarded under subsection (b) are distributed equitably among the 
various regions of the United States and among rural, urban, and 
suburban areas that are affected by the use of heroin or other opioids.
    ``(d) Additional Activities.--In administering grants under 
subsection (b), the Secretary shall--
            ``(1) evaluate the activities supported by grants awarded 
        under subsection (b);
            ``(2) disseminate information, as appropriate, derived from 
        the evaluation as the Secretary considers appropriate;
            ``(3) provide States, Indian tribes and tribal 
        organizations, and providers with technical assistance in 
        connection with the provision of treatment of problems related 
        to heroin and other opioids; and
            ``(4) fund only those applications that specifically 
        support recovery services as a critical component of the grant 
        program.''.

SEC. 302. CRIMINAL JUSTICE MEDICATION ASSISTED TREATMENT AND 
              INTERVENTIONS DEMONSTRATION.

    (a) Definitions.--In this section--
            (1) the term ``criminal justice agency'' means a State, 
        local, or tribal--
                    (A) court;
                    (B) prison;
                    (C) jail; or
                    (D) other agency that performs the administration 
                of criminal justice, including prosecution, pretrial 
                services, and community supervision;
            (2) the term ``eligible entity'' means a State, unit of 
        local government, or Indian tribe; and
            (3) the term ``Secretary'' means the Secretary of Health 
        and Human Services.
    (b) Program Authorized.--The Secretary, in coordination with the 
Attorney General, may make grants to eligible entities to implement 
medication assisted treatment programs through criminal justice 
agencies.
    (c) Application.--
            (1) In general.--An eligible entity seeking a grant under 
        this section shall submit an application to the Secretary--
                    (A) that meets the criteria under paragraph (2); 
                and
                    (B) at such time, in such manner, and accompanied 
                by such information as the Secretary may require.
            (2) Criteria.--An eligible entity, in submitting an 
        application under paragraph (1), shall--
                    (A) certify that each medication assisted treatment 
                program funded with a grant under this section has been 
                developed in consultation with the Single State 
                Authority for Substance Abuse; and
                    (B) describe how data will be collected and 
                analyzed to determine the effectiveness of the program 
                described in subparagraph (A).
    (d) Use of Funds.--An eligible entity shall use a grant received 
under this section for expenses of--
            (1) a medication assisted treatment program, including the 
        expenses of prescribing medications recognized by the Food and 
        Drug Administration for opioid treatment in conjunction with 
        psychological and behavioral therapy;
            (2) training criminal justice agency personnel and 
        treatment providers on medication assisted treatment;
            (3) cross-training personnel providing behavioral health 
        and health services, administration of medicines, and other 
        administrative expenses, including required reports; and
            (4) the provision of recovery coaches who are responsible 
        for providing mentorship and transition plans to individuals 
        reentering society following incarceration or alternatives to 
        incarceration.
    (e) Priority Consideration With Respect to States.--In awarding 
grants to States under this section, the Secretary shall give priority 
to a State that--
            (1) provides civil liability protection for first 
        responders, health professionals, and family members who have 
        received appropriate training in the administration of naloxone 
        in administering naloxone to counteract opioid overdoses; and
            (2) submits to the Secretary a certification by the 
        attorney general of the State that the attorney general has--
                    (A) reviewed any applicable civil liability 
                protection law to determine the applicability of the 
                law with respect to first responders, health care 
                professionals, family members, and other individuals 
                who--
                            (i) have received appropriate training in 
                        the administration of naloxone; and
                            (ii) may administer naloxone to individuals 
                        reasonably believed to be suffering from opioid 
                        overdose; and
                    (B) concluded that the law described in 
                subparagraph (A) provides adequate civil liability 
                protection applicable to such persons.
    (f) Technical Assistance.--The Secretary, in coordination with the 
Director of the National Institute on Drug Abuse and the Attorney 
General, shall provide technical assistance and training for an 
eligible entity receiving a grant under this section.
    (g) Reports.--
            (1) In general.--An eligible entity receiving a grant under 
        this section shall submit a report to the Secretary on the 
        outcomes of each grant received under this section for 
        individuals receiving medication assisted treatment, based on--
                    (A) the recidivism of the individuals;
                    (B) the treatment outcomes of the individuals, 
                including maintaining abstinence from illegal, 
                unauthorized, and unprescribed or undispensed opioids 
                and heroin;
                    (C) a comparison of the cost of providing 
                medication assisted treatment to the cost of 
                incarceration or other participation in the criminal 
                justice system;
                    (D) the housing status of the individuals; and
                    (E) the employment status of the individuals.
            (2) Contents and timing.--Each report described in 
        paragraph (1) shall be submitted annually in such form, 
        containing such information, and on such dates as the Secretary 
        shall specify.
    (h) Funding.--During the 5-year period beginning on the date of 
enactment of this Act, the Secretary shall carry out this section using 
funds made available to the Substance Abuse and Mental Health Services 
Administration for Criminal Justice Activities.

SEC. 303. NATIONAL YOUTH RECOVERY INITIATIVE.

    Part II of title I of the Omnibus Crime Control and Safe Streets 
Act of 1968 (42 U.S.C. 3797cc et seq.), as amended by section 301, is 
amended by adding at the end the following:

``SEC. 2999B. NATIONAL YOUTH RECOVERY INITIATIVE.

    ``(a) Definitions.--In this section:
            ``(1) Eligible entity.--The term `eligible entity' means--
                    ``(A) a high school that has been accredited as a 
                recovery high school by the Association of Recovery 
                Schools;
                    ``(B) an accredited high school that is seeking to 
                establish or expand recovery support services;
                    ``(C) an institution of higher education;
                    ``(D) a recovery program at a nonprofit collegiate 
                institution; or
                    ``(E) a nonprofit organization.
            ``(2) Institution of higher education.--The term 
        `institution of higher education' has the meaning given the 
        term in section 101 of the Higher Education Act of 1965 (20 
        U.S.C. 1001).
            ``(3) Recovery program.--The term `recovery program'--
                    ``(A) means a program to help individuals who are 
                recovering from substance use disorders to initiate, 
                stabilize, and maintain healthy and productive lives in 
                the community; and
                    ``(B) includes peer-to-peer support and communal 
                activities to build recovery skills and supportive 
                social networks.
    ``(b) Grants Authorized.--The Secretary of Health and Human 
Services, in coordination with the Secretary of Education, may award 
grants to eligible entities to enable the entities to--
            ``(1) provide substance use recovery support services to 
        young people in high school and enrolled in institutions of 
        higher education;
            ``(2) help build communities of support for young people in 
        recovery through a spectrum of activities such as counseling 
        and health- and wellness-oriented social activities; and
            ``(3) encourage initiatives designed to help young people 
        achieve and sustain recovery from substance use disorders.
    ``(c) Use of Funds.--Grants awarded under subsection (b) may be 
used for activities to develop, support, and maintain youth recovery 
support services, including--
            ``(1) the development and maintenance of a dedicated 
        physical space for recovery programs;
            ``(2) dedicated staff for the provision of recovery 
        programs;
            ``(3) health- and wellness-oriented social activities and 
        community engagement;
            ``(4) establishment of recovery high schools;
            ``(5) coordination of recovery programs with--
                    ``(A) substance use disorder treatment programs and 
                systems;
                    ``(B) providers of mental health services;
                    ``(C) primary care providers and physicians;
                    ``(D) the criminal justice system, including the 
                juvenile justice system;
                    ``(E) employers;
                    ``(F) housing services;
                    ``(G) child welfare services;
                    ``(H) high schools and institutions of higher 
                education; and
                    ``(I) other programs or services related to the 
                welfare of an individual in recovery from a substance 
                use disorder;
            ``(6) the development of peer-to-peer support programs or 
        services; and
            ``(7) additional activities that help youths and young 
        adults to achieve recovery from substance use disorders.''.

SEC. 304. BUILDING COMMUNITIES OF RECOVERY.

    Part II of title I of the Omnibus Crime Control and Safe Streets 
Act of 1968 (42 U.S.C. 3797cc et seq.), as amended by section 303, is 
amended by adding at the end the following:

``SEC. 2999C. BUILDING COMMUNITIES OF RECOVERY.

    ``(a) Definition.--In this section, the term `recovery community 
organization' means an independent nonprofit organization that--
            ``(1) mobilizes resources within and outside of the 
        recovery community to increase the prevalence and quality of 
        long-term recovery from substance use disorders; and
            ``(2) is wholly or principally governed by people in 
        recovery for substance use disorders who reflect the community 
        served.
    ``(b) Grants Authorized.--The Secretary of Health and Human 
Services may award grants to recovery community organizations to enable 
such organizations to develop, expand, and enhance recovery services.
    ``(c) Federal Share.--The Federal share of the costs of a program 
funded by a grant under this section may not exceed 50 percent.
    ``(d) Use of Funds.--Grants awarded under subsection (b)--
            ``(1) shall be used to develop, expand, and enhance 
        community and statewide recovery support services; and
            ``(2) may be used to--
                    ``(A) advocate for individuals in recovery from 
                substance use disorders;
                    ``(B) build connections between recovery networks, 
                between recovery community organizations, and with 
                other recovery support services, including--
                            ``(i) substance use disorder treatment 
                        programs and systems;
                            ``(ii) providers of mental health services;
                            ``(iii) primary care providers and 
                        physicians;
                            ``(iv) the criminal justice system;
                            ``(v) employers;
                            ``(vi) housing services;
                            ``(vii) child welfare agencies; and
                            ``(viii) other recovery support services 
                        that facilitate recovery from substance use 
                        disorders;
                    ``(C) reduce the stigma associated with substance 
                use disorders;
                    ``(D) conduct public education and outreach on 
                issues relating to substance use disorders and 
                recovery, including--
                            ``(i) how to identify the signs of 
                        addiction;
                            ``(ii) the resources that are available to 
                        individuals struggling with addiction and 
                        families who have a family member struggling 
                        with or being treated for addiction, including 
                        programs that mentor and provide support 
                        services to children;
                            ``(iii) the resources that are available to 
                        help support individuals in recovery; and
                            ``(iv) information on the medical 
                        consequences of substance use disorders, 
                        including neonatal abstinence syndrome and 
                        potential infection with human immunodeficiency 
                        virus and viral hepatitis; and
                    ``(E) carry out other activities that strengthen 
                the network of community support for individuals in 
                recovery.''.

              TITLE IV--ADDRESSING COLLATERAL CONSEQUENCES

SEC. 401. CORRECTIONAL EDUCATION DEMONSTRATION GRANT PROGRAM.

    Part II of title I of the Omnibus Crime Control and Safe Streets 
Act of 1968 (42 U.S.C. 3797cc et seq.), as amended by section 304, is 
amended by adding at the end the following:

``SEC. 2999D. CORRECTIONAL EDUCATION DEMONSTRATION GRANT PROGRAM.

    ``(a) Definition.--In this section, the term `eligible entity' 
means a State, unit of local government, nonprofit organization, or 
Indian tribe.
    ``(b) Grant Program Authorized.--The Attorney General may make 
grants to eligible entities to design, implement, and expand 
educational programs for offenders in prisons, jails, and juvenile 
facilities, including to pay for--
            ``(1) basic education, secondary level academic education, 
        high school equivalency examination preparation, career 
        technical education, and English as a second language 
        instruction at the basic, secondary, or post-secondary levels, 
        for adult and juvenile populations;
            ``(2) screening and assessment of inmates to assess 
        education level, needs, occupational interest or aptitude, risk 
        level, and other needs, and case management services;
            ``(3) hiring and training of instructors and aides, 
        reimbursement of non-corrections staff and experts, 
        reimbursement of stipends paid to inmate tutors or aides, and 
        the costs of training inmate tutors and aides;
            ``(4) instructional supplies and equipment, including 
        occupational program supplies and equipment to the extent that 
        the supplies and equipment are used for instructional purposes;
            ``(5) partnerships and agreements with community colleges, 
        universities, and career technology education program 
        providers;
            ``(6) certification programs providing recognized high 
        school equivalency certificates and industry recognized 
        credentials; and
            ``(7) technology solutions to--
                    ``(A) meet the instructional, assessment, and 
                information needs of correctional populations; and
                    ``(B) facilitate the continued participation of 
                incarcerated students in community-based education 
                programs after the students are released from 
                incarceration.
    ``(c) Application.--An eligible entity seeking a grant under this 
section shall submit to the Attorney General an application in such 
form and manner, at such time, and accompanied by such information as 
the Attorney General specifies.
    ``(d) Priority Considerations.--In awarding grants under this 
section, the Attorney General shall give priority to applicants that--
            ``(1) assess the level of risk and need of inmates, 
        including by--
                    ``(A) assessing the need for English as a second 
                language instruction;
                    ``(B) conducting educational assessments; and
                    ``(C) assessing occupational interests and 
                aptitudes;
            ``(2) target educational services to assessed needs, 
        including academic and occupational at the basic, secondary, or 
        post-secondary level;
            ``(3) target career technology education programs to--
                    ``(A) areas of identified occupational demand; and
                    ``(B) employment opportunities in the communities 
                in which students are reasonably expected to reside 
                post-release;
            ``(4) include a range of appropriate educational 
        opportunities at the basic, secondary, and post-secondary 
        levels;
            ``(5) include opportunities for students to attain industry 
        recognized credentials;
            ``(6) include partnership or articulation agreements 
        linking institutional education programs with community sited 
        programs provided by adult education program providers and 
        accredited institutions of higher education, community 
        colleges, and vocational training institutions; and
            ``(7) explicitly include career pathways models offering 
        opportunities for incarcerated students to develop academic 
        skills, in-demand occupational skills and credentials, 
        occupational experience in institutional work programs or work 
        release programs, and linkages with employers in the community, 
        so that incarcerated students have opportunities to embark on 
        careers with strong prospects for both post-release employment 
        and advancement in a career ladder over time.
    ``(e) Requirements.--An eligible entity desiring a grant under this 
section shall--
            ``(1) describe the evidence-based methodology and outcome 
        measurements that will be used to evaluate each program funded 
        with a grant under this section, and specifically explain how 
        such measurements will provide valid measures of the impact of 
        the program; and
            ``(2) describe how the program described in paragraph (1) 
        could be broadly replicated if demonstrated to be effective.
    ``(f) Control of Internet Access.--An entity that receives a grant 
under this section may restrict access to the Internet by prisoners, as 
appropriate and in accordance with Federal and State law, to ensure 
public safety.''.

SEC. 402. NATIONAL TASK FORCE ON RECOVERY AND COLLATERAL CONSEQUENCES.

    (a) Definition.--In this section, the term ``collateral 
consequence'' means a penalty, disability, or disadvantage imposed on 
an individual who is in recovery for a substance use disorder 
(including by an administrative agency, official, or civil court ) as a 
result of a Federal or State conviction for a drug-related offense but 
not as part of the judgment of the court that imposes the conviction.
    (b) Establishment.--
            (1) In general.--Not later than 30 days after the date of 
        enactment of this Act, the Attorney General shall establish a 
        bipartisan task force to be known as the Task Force on Recovery 
        and Collateral Consequences (in this section referred to as the 
        ``Task Force'').
            (2) Membership.--
                    (A) Total number of members.--The Task Force shall 
                include 10 members, who shall be appointed by the 
                Attorney General in accordance with subparagraphs (B) 
                and (C).
                    (B) Members of the task force.--The Task Force 
                shall include--
                            (i) members who have national recognition 
                        and significant expertise in areas such as 
                        health care, housing, employment, substance use 
                        disorders, mental health, law enforcement, and 
                        law;
                            (ii) not fewer than 2 members--
                                    (I) who have personally experienced 
                                substance abuse or addiction and are in 
                                recovery; and
                                    (II) not fewer than 1 one of whom 
                                has benefitted from medication assisted 
                                treatment; and
                            (iii) to the extent practicable, members 
                        who formerly served as elected officials at the 
                        State and Federal levels.
                    (C) Timing.--The Attorney General shall appoint the 
                members of the Task Force not later than 60 days after 
                the date on which the Task Force is established under 
                paragraph (1).
            (3) Chairperson.--The Task Force shall select a chairperson 
        or co-chairpersons from among the members of the Task Force.
    (c) Duties of the Task Force.--
            (1) In general.--The Task Force shall--
                    (A) identify collateral consequences for 
                individuals with Federal or State convictions for drug-
                related offenses who are in recovery for substance use 
                disorder; and
                    (B) examine any policy basis for the imposition of 
                collateral consequences identified under subparagraph 
                (A) and the effect of the collateral consequences on 
                individuals in recovery from resuming their personal 
                and professional activities.
            (2) Recommendations.--Not later than 180 days after the 
        date of the first meeting of the Task Force, the Task Force 
        shall develop recommendations, as it considers appropriate, for 
        proposed legislative and regulatory changes related to the 
        collateral consequences identified under paragraph (1).
            (3) Collection of information.--The Task Force shall hold 
        hearings, require the testimony and attendance of witnesses, 
        and secure information from any department or agency of the 
        United States in performing the duties under paragraphs (1) and 
        (2).
            (4) Report.--
                    (A) Submission to executive branch.--Not later than 
                1 year after the date of the first meeting of the Task 
                Force, the Task Force shall submit a report detailing 
                the findings and recommendations of the Task Force to--
                            (i) the head of each relevant department or 
                        agency of the United States;
                            (ii) the President; and
                            (iii) the Vice President.
                    (B) Submission to congress.--The individuals who 
                receive the report under subparagraph (A) shall submit 
                to Congress such legislative recommendations, if any, 
                as those individuals consider appropriate based on the 
                report.

  TITLE V--ADDICTION AND TREATMENT SERVICES FOR WOMEN, FAMILIES, AND 
                                VETERANS

SEC. 501. IMPROVING TREATMENT FOR PREGNANT AND POSTPARTUM WOMEN.

    Part II of title I of the Omnibus Crime Control and Safe Streets 
Act of 1968 (42 U.S.C. 3797cc et seq.), as amended by section 401, is 
amended by adding at the end the following:

``SEC. 2999E. IMPROVING TREATMENT FOR PREGNANT AND POSTPARTUM WOMEN.

    ``(a) In General.--The Secretary of Health and Human Services 
(referred to in this section as the `Secretary'), acting through the 
Director of the Center for Substance Abuse Treatment, may carry out a 
pilot program under which the Secretary makes competitive grants to 
State substance abuse agencies to--
            ``(1) enhance flexibility in the use of funds designed to 
        support family-based services for pregnant and postpartum women 
        with a primary diagnosis of a substance use disorder, including 
        opioid use disorders;
            ``(2) help State substance abuse agencies address 
        identified gaps in services furnished to such women along the 
        continuum of care, including services provided to women in non-
        residential based settings; and
            ``(3) promote a coordinated, effective, and efficient State 
        system managed by State substance abuse agencies by encouraging 
        new approaches and models of service delivery that are 
        evidence-based, including effective family-based programs for 
        women involved with the criminal justice system.
    ``(b) Requirements.--In carrying out the pilot program under this 
section, the Secretary--
            ``(1) shall require State substance abuse agencies to 
        submit to the Secretary applications, in such form and manner 
        and containing such information as specified by the Secretary, 
        to be eligible to receive a grant under the program;
            ``(2) shall identify, based on such submitted applications, 
        State substance abuse agencies that are eligible for such 
        grants;
            ``(3) shall require services proposed to be furnished 
        through such a grant to support family-based treatment and 
        other services for pregnant and postpartum women with a primary 
        diagnosis of a substance use disorder, including opioid use 
        disorders;
            ``(4) shall not require that services furnished through 
        such a grant be provided solely to women that reside in 
        facilities; and
            ``(5) shall not require that grant recipients under the 
        program make available all services described in section 508(d) 
        of the Public Health Service Act (42 U.S.C. 290bb-1(d)).
    ``(c) Required Services.--
            ``(1) In general.--The Secretary shall specify minimum 
        services required to be made available to eligible women 
        through a grant awarded under the pilot program under this 
        section. Such minimum services--
                    ``(A) shall include the requirements described in 
                section 508(c) of the Public Health Service Act (42 
                U.S.C. 290bb-1(c));
                    ``(B) may include any of the services described in 
                section 508(d) of the Public Health Service Act (42 
                U.S.C. 290bb-1(d));
                    ``(C) may include other services, as appropriate; 
                and
                    ``(D) shall be based on the recommendations 
                submitted under paragraph (2).
            ``(2) Stakeholder input.--The Secretary shall convene and 
        solicit recommendations from stakeholders, including State 
        substance abuse agencies, health care providers, persons in 
        recovery from a substance use disorder, and other appropriate 
        individuals, for the minimum services described in paragraph 
        (1).
    ``(d) Duration.--The pilot program under this section shall not 
exceed 5 years.
    ``(e) Evaluation and Report to Congress.--
            ``(1) In general.--Out of amounts made available to the 
        Center for Behavioral Health Statistics and Quality, the 
        Director of the Center for Behavioral Health Statistics and 
        Quality, in cooperation with the recipients of grants under 
        this section, shall conduct an evaluation of the pilot program, 
        beginning 1 year after the date on which a grant is first 
        awarded under this section. The Director of the Center for 
        Behavioral Health Statistics and Quality, in coordination with 
        the Director of the Center for Substance Abuse Treatment, not 
        later than 120 days after completion of such evaluation, shall 
        submit to the relevant Committees of the Senate and the House 
        of Representatives a report on such evaluation.
            ``(2) Contents.--The report to Congress under paragraph (1) 
        shall include, at a minimum, outcomes information from the 
        pilot program, including any resulting reductions in the use of 
        alcohol and other drugs, engagement in treatment services, 
        retention in the appropriate level and duration of services, 
        increased access to the use of drugs approved by the Food and 
        Drug Administration for the treatment of substance use 
        disorders in combination with counseling, and other appropriate 
        measures.
    ``(f) State Substance Abuse Agency Defined.--For purposes of this 
section, the term `State substance abuse agency' means, with respect to 
a State, the agency in such State that manages the substance abuse 
prevention and treatment block grant program under part B of title XIX 
of the Public Health Service Act.''.

SEC. 502. REPORT ON GRANTS FOR FAMILY-BASED SUBSTANCE ABUSE TREATMENT.

    Section 2925 of the Omnibus Crime Control and Safe Streets Act of 
1968 (42 U.S.C. 3797s-4) is amended--
            (1) by striking ``An entity'' and inserting ``(a) Entity 
        Reports.--An entity''; and
            (2) by adding at the end the following:
    ``(b) Attorney General Report on Family-Based Substance Abuse 
Treatment.--The Attorney General shall submit to Congress an annual 
report that describes the number of grants awarded under section 
2921(1) and how such grants are used by the recipients for family-based 
substance abuse treatment programs that serve as alternatives to 
incarceration for custodial parents to receive treatment and services 
as a family.''.

SEC. 503. VETERANS' TREATMENT COURTS.

    Section 2991(j)(1)(B)(ii) of title I of the Omnibus Crime Control 
and Safe Streets Act of 1968 (42 U.S.C. 3797aa(j)(1)(B)(ii)) is 
amended--
            (1) by inserting ``(I)'' after ``(ii)'';
            (2) in subclause (I), as so designated, by striking the 
        period and inserting ``; or''; and
            (3) by adding at the end the following:
                            ``(II) was discharged or released from such 
                        service under dishonorable conditions, if the 
                        reason for that discharge or release, if known, 
                        is attributable to drug use.''.

  TITLE VI--INCENTIVIZING STATE COMPREHENSIVE INITIATIVES TO ADDRESS 
                        OPIOID AND HEROIN ABUSE

SEC. 601. STATE DEMONSTRATION GRANTS FOR COMPREHENSIVE OPIOID ABUSE 
              RESPONSE.

    (a) Definitions.--In this section--
            (1) the term ``dispenser'' has the meaning given the term 
        in section 102 of the Controlled Substances Act (21 U.S.C. 
        802);
            (2) the term ``prescriber of a schedule II, III, or IV 
        controlled substance'' does not include a prescriber of a 
        schedule II, III, or IV controlled substance that dispenses the 
        substance--
                    (A) for use on the premises on which the substance 
                is dispensed;
                    (B) in a hospital emergency room, when the 
                substance is in short supply;
                    (C) for a certified opioid treatment program; or
                    (D) in other situations as the Attorney General may 
                reasonably determine;
            (3) the term ``prescriber'' means a dispenser who 
        prescribes a controlled substance, or the agent of such a 
        dispenser; and
            (4) the term ``schedule II, III, or IV controlled 
        substance'' means a controlled substance that is listed on 
        schedule II, schedule III, or schedule IV of section 202(c) of 
        the Controlled Substances Act (21 U.S.C. 812(c)).
    (b) Planning and Implementation Grants.--
            (1) In general.--The Attorney General, in coordination with 
        the Secretary of Health and Human Services and in consultation 
        with the Director of the Office of National Drug Control 
        Policy, may award grants to States, and combinations thereof, 
        to prepare a comprehensive plan for and implement an integrated 
        opioid abuse response initiative.
            (2) Purposes.--A State receiving a grant under this section 
        shall establish a comprehensive response to opioid abuse, which 
        shall include--
                    (A) prevention and education efforts around heroin 
                and opioid use, treatment, and recovery, including 
                education of residents, medical students, and 
                physicians and other prescribers of schedule II, III, 
                or IV controlled substances on relevant prescribing 
                guidelines and the prescription drug monitoring program 
                of the State ;
                    (B) a comprehensive prescription drug monitoring 
                program to track dispensing of schedule II, III, or IV 
                controlled substances, which shall--
                            (i) provide for data sharing with other 
                        States by statute, regulation, or interstate 
                        agreement; and
                            (ii) allow for access to all individuals 
                        authorized by the State to write prescriptions 
                        for schedule II, III, or IV controlled 
                        substances on the prescription drug monitoring 
                        program of the State.
                    (C) developing, implementing, or expanding 
                prescription drug and opioid addiction treatment 
                programs by--
                            (i) expanding programs for medication 
                        assisted treatment of prescription drug and 
                        opioid addiction, including training for 
                        treatment and recovery support providers;
                            (ii) developing, implementing, or expanding 
                        programs for behavioral health therapy for 
                        individuals who are in treatment for 
                        prescription drug and opioid addiction;
                            (iii) developing, implementing, or 
                        expanding programs to screen individuals who 
                        are in treatment for prescription drug and 
                        opioid addiction for hepatitis C and HIV, and 
                        provide treatment for those individuals if 
                        clinically appropriate; or
                            (iv) developing, implementing, or expanding 
                        programs that provide screening, early 
                        intervention, and referral to treatment 
                        (commonly known as ``SBIRT'') to teenagers and 
                        young adults in primary care, middle schools, 
                        high schools, universities, school-based health 
                        centers, and other community-based health care 
                        settings frequently accessed by teenagers or 
                        young adults; and
                    (D) developing, implementing, and expanding 
                programs to prevent overdose death from prescription 
                medications and opioids.
            (3) Planning grant applications.--
                    (A) Application.--
                            (i) In general.--A State seeking a planning 
                        grant under this section to prepare a 
                        comprehensive plan for an integrated opioid 
                        abuse response initiative shall submit to the 
                        Attorney General an application in such form, 
                        and containing such information, as the 
                        Attorney General may require.
                            (ii) Requirements.--An application for a 
                        planning grant under this section shall, at a 
                        minimum, include--
                                    (I) a budget and a budget 
                                justification for the activities to be 
                                carried out using the grant;
                                    (II) a description of the 
                                activities proposed to be carried out 
                                using the grant, including a schedule 
                                for completion of such activities;
                                    (III) outcome measures that will be 
                                used to measure the effectiveness of 
                                the programs and initiatives to address 
                                opioids; and
                                    (IV) a description of the personnel 
                                necessary to complete such activities.
                    (B) Period; nonrenewability.--A planning grant 
                under this section shall be for a period of 1 year. A 
                State may not receive more than 1 planning grant under 
                this section.
                    (C) Amount.--A planning grant under this section 
                may not exceed $100,000.
                    (D) Strategic plan and program implementation 
                plan.--A State receiving a planning grant under this 
                section shall develop a strategic plan and a program 
                implementation plan.
            (4) Implementation grants.--
                    (A) Application.--A State seeking an implementation 
                grant under this section to implement a comprehensive 
                strategy for addressing opioid abuse shall submit to 
                the Attorney General an application in such form, and 
                containing such information, as the Attorney General 
                may require.
                    (B) Use of funds.--A State that receives an 
                implementation grant under this section shall use the 
                grant for the cost of carrying out an integrated opioid 
                abuse response program in accordance with this section, 
                including for technical assistance, training, and 
                administrative expenses.
                    (C) Requirements.--An integrated opioid abuse 
                response program carried out using an implementation 
                grant under this section shall--
                            (i) require that each prescriber of a 
                        schedule II, III, or IV controlled substance in 
                        the State--
                                    (I) registers with the prescription 
                                drug monitoring program of the State; 
                                and
                                    (II) consults the prescription drug 
                                monitoring program database of the 
                                State before prescribing a schedule II, 
                                III, or IV controlled substance;
                            (ii) require that each dispenser of a 
                        schedule II, III, or IV controlled substance in 
                        the State--
                                    (I) registers with the prescription 
                                drug monitoring program of the State;
                                    (II) consults the prescription drug 
                                monitoring program database of the 
                                State before dispensing a schedule II, 
                                III, or IV controlled substance; and
                                    (III) reports to the prescription 
                                drug monitoring program of the State, 
                                at a minimum, each instance in which a 
                                schedule II, III, or IV controlled 
                                substance is dispensed, with limited 
                                exceptions, as defined by the State, 
                                which shall indicate the prescriber by 
                                name and National Provider Identifier;
                            (iii) require that, not fewer than 4 times 
                        each year, the State agency or agencies that 
                        administer the prescription drug monitoring 
                        program of the State prepare and provide to 
                        each prescriber of a schedule II, III, or IV 
                        controlled substance an informational report 
                        that shows how the prescribing patterns of the 
                        prescriber compare to prescribing practices of 
                        the peers of the prescriber and expected norms;
                            (iv) if informational reports provided to a 
                        prescriber under clause (iii) indicate that the 
                        prescriber is repeatedly falling outside of 
                        expected norms or standard practices for the 
                        prescriber's field, direct the prescriber to 
                        educational resources on appropriate 
                        prescribing of controlled substances;
                            (v) ensure that the prescriber licensing 
                        board of the State receives a report describing 
                        any prescribers that repeatedly fall outside of 
                        expected norms or standard practices for the 
                        prescriber's field, as described in clause 
                        (iii);
                            (vi) require consultation with the Single 
                        State Authority for Substance Abuse; and
                            (vii) establish requirements for how data 
                        will be collected and analyzed to determine the 
                        effectiveness of the program.
                    (D) Period.--An implementation grant under this 
                section shall be for a period of 2 years.
                    (E) Amount.--The amount of an implementation grant 
                under this section may not exceed $5,000,000.
            (5) Priority considerations.--In awarding planning and 
        implementation grants under this section, the Attorney General 
        shall give priority to a State that--
                    (A)(i) provides civil liability protection for 
                first responders, health professionals, and family 
                members who have received appropriate training in the 
                administration of naloxone in administering naloxone to 
                counteract opioid overdoses; and
                    (ii) submits to the Attorney General a 
                certification by the attorney general of the State that 
                the attorney general has--
                            (I) reviewed any applicable civil liability 
                        protection law to determine the applicability 
                        of the law with respect to first responders, 
                        health care professionals, family members, and 
                        other individuals who--
                                    (aa) have received appropriate 
                                training in the administration of 
                                naloxone; and
                                    (bb) may administer naloxone to 
                                individuals reasonably believed to be 
                                suffering from opioid overdose; and
                            (II) concluded that the law described in 
                        subclause (I) provides adequate civil liability 
                        protection applicable to such persons;
                    (B) has in effect legislation or implements a 
                policy under which the State shall not terminate, but 
                may suspend, enrollment under the State plan for 
                medical assistance under title XIX of the Social 
                Security Act (42 U.S.C. 1396 et seq.) for an individual 
                who is incarcerated for a period of fewer than 2 years;
                    (C) has a process for enrollment in services and 
                benefits necessary by criminal justice agencies to 
                initiate or continue treatment in the community, under 
                which an individual who is incarcerated may, while 
                incarcerated, enroll in services and benefits that are 
                necessary for the individual to continue treatment upon 
                release from incarceration;
                    (D) ensures the capability of data sharing with 
                other States, such as by making data available to a 
                prescription monitoring hub;
                    (E) ensures that data recorded in the prescription 
                drug monitoring program database of the State is 
                available within 24 hours, to the extent possible; and
                    (F) ensures that the prescription drug monitoring 
                program of the State notifies prescribers and 
                dispensers of schedule II, III, or IV controlled 
                substances when overuse or misuse of such controlled 
                substances by patients is suspected.
    (c) Authorization of Funding.--For each of fiscal years 2016 
through 2020, the Attorney General may use, from any unobligated 
balances made available under the heading ``GENERAL ADMINISTRATION'' to 
the Department of Justice in an appropriations Act, such amounts as are 
necessary to carry out this section, not to exceed $5,000,000 per 
fiscal year.

                        TITLE VII--MISCELLANEOUS

SEC. 701. GAO REPORT ON IMD EXCLUSION.

    (a) Definition.--In this section, the term ``Medicaid Institutions 
for Mental Disease exclusion'' means the prohibition on Federal 
matching payments under Medicaid for patients who have attained age 22, 
but have not attained age 65, in an institution for mental diseases 
under subparagraph (B) of the matter following subsection (a) of 
section 1905 of the Social Security Act and subsection (i) of such 
section (42 U.S.C. 1396d).
    (b) Report Required.--Not later than 1 year after the date of 
enactment of this Act, the Comptroller General of the United States 
shall submit to Congress a report on the impact that the Medicaid 
Institutions for Mental Disease exclusion has on access to treatment 
for individuals with a substance use disorder.
    (c) Elements.--The report required under subsection (b) shall 
include a review of what is known regarding--
            (1) Medicaid beneficiary access to substance use disorder 
        treatments in institutions for mental disease; and
            (2) the quality of care provided to Medicaid beneficiaries 
        treated in and outside of institutions for mental disease for 
        substance use disorders.

SEC. 702. FUNDING.

    Part II of title I of the Omnibus Crime Control and Safe Streets 
Act of 1968 (42 U.S.C. 3797cc et seq.), as amended by section 501, is 
amended by adding at the end the following:

``SEC. 2999F. FUNDING.

    ``There are authorized to be appropriated to the Attorney General 
and the Secretary of Health and Human Services to carry out this part 
$77,900,000 for each of fiscal years 2016 through 2020.''.

SEC. 703. CONFORMING AMENDMENTS.

    Part II of title I of the Omnibus Crime Control and Safe Streets 
Act of 1968 (42 U.S.C. 3797cc et seq.) is amended--
            (1) in the part heading, by striking ``confronting use of 
        methamphetamine'' and inserting ``comprehensive addiction and 
        recovery''; and
            (2) in section 2996(a)(1), by striking ``this part'' and 
        inserting ``this section''.

SEC. 704. GRANT ACCOUNTABILITY.

    (a) Grants Under Part II of Title I of the Omnibus Crime Control 
and Safe Streets Act of 1968.--
            Part II of title I of the Omnibus Crime Control and Safe 
        Streets Act of 1968 (42 U.S.C. 3797cc et seq.), as amended by 
        section 702, is amended by adding at the end the following:

``SEC. 2999G. GRANT ACCOUNTABILITY.

    ``(a) Definitions.--In this section--
            ``(1) the term `applicable committees'--
                    ``(A) with respect to the Attorney General and any 
                other official of the Department of Justice, means--
                            ``(i) the Committee on the Judiciary of the 
                        Senate; and
                            ``(ii) the Committee on the Judiciary of 
                        the House of Representatives; and
                    ``(B) with respect to the Secretary of Health and 
                Human Services and any other official of the Department 
                of Health and Human Services, means--
                            ``(i) the Committee on Health, Education, 
                        Labor, and Pensions of the Senate; and
                            ``(ii) the Committee on Energy and Commerce 
                        of the House of Representatives;
            ``(2) the term `covered agency' means--
                    ``(A) the Department of Justice; and
                    ``(B) the Department of Health and Human Services; 
                and
            ``(3) the term `covered official' means--
                    ``(A) the Attorney General; and
                    ``(B) the Secretary of Health and Human Services.
    ``(b) Accountability.--All grants awarded by a covered official 
under this part shall be subject to the following accountability 
provisions:
            ``(1) Audit requirement.--
                    ``(A) Definition.--In this paragraph, the term 
                `unresolved audit finding' means a finding in the final 
                audit report of the Inspector General of a covered 
                agency that the audited grantee has utilized grant 
                funds for an unauthorized expenditure or otherwise 
                unallowable cost that is not closed or resolved within 
                12 months after the date on which the final audit 
                report is issued.
                    ``(B) Audit.--Beginning in the first fiscal year 
                beginning after the date of enactment of this section, 
                and in each fiscal year thereafter, the Inspector 
                General of a covered agency shall conduct audits of 
                recipients of grants awarded by the applicable covered 
                official under this part to prevent waste, fraud, and 
                abuse of funds by grantees. The Inspector General shall 
                determine the appropriate number of grantees to be 
                audited each year.
                    ``(C) Mandatory exclusion.--A recipient of grant 
                funds under this part that is found to have an 
                unresolved audit finding shall not be eligible to 
                receive grant funds under this part during the first 2 
                fiscal years beginning after the end of the 12-month 
                period described in subparagraph (A).
                    ``(D) Priority.--In awarding grants under this 
                part, a covered official shall give priority to 
                eligible applicants that did not have an unresolved 
                audit finding during the 3 fiscal years before 
                submitting an application for a grant under this part.
                    ``(E) Reimbursement.--If an entity is awarded grant 
                funds under this part during the 2-fiscal-year period 
                during which the entity is barred from receiving grants 
                under subparagraph (C), the covered official that 
                awarded the grant funds shall--
                            ``(i) deposit an amount equal to the amount 
                        of the grant funds that were improperly awarded 
                        to the grantee into the General Fund of the 
                        Treasury; and
                            ``(ii) seek to recoup the costs of the 
                        repayment to the fund from the grant recipient 
                        that was erroneously awarded grant funds.
            ``(2) Nonprofit organization requirements.--
                    ``(A) Definition.--For purposes of this paragraph 
                and the grant programs under this part, the term 
                `nonprofit organization' means an organization that is 
                described in section 501(c)(3) of the Internal Revenue 
                Code of 1986 and is exempt from taxation under section 
                501(a) of such Code.
                    ``(B) Prohibition.--A covered official may not 
                award a grant under this part to a nonprofit 
                organization that holds money in offshore accounts for 
                the purpose of avoiding paying the tax described in 
                section 511(a) of the Internal Revenue Code of 1986.
                    ``(C) Disclosure.--Each nonprofit organization that 
                is awarded a grant under this part and uses the 
                procedures prescribed in regulations to create a 
                rebuttable presumption of reasonableness for the 
                compensation of its officers, directors, trustees, and 
                key employees, shall disclose to the applicable covered 
                official, in the application for the grant, the process 
                for determining such compensation, including the 
                independent persons involved in reviewing and approving 
                such compensation, the comparability data used, and 
                contemporaneous substantiation of the deliberation and 
                decision. Upon request, a covered official shall make 
                the information disclosed under this subparagraph 
                available for public inspection.
            ``(3) Conference expenditures.--
                    ``(A) Limitation.--No amounts made available to a 
                covered official under this part may be used by the 
                covered official, or by any individual or entity 
                awarded discretionary funds through a cooperative 
                agreement under this part, to host or support any 
                expenditure for conferences that uses more than $20,000 
                in funds made available by the covered official, unless 
                the covered official provides prior written 
                authorization that the funds may be expended to host 
                the conference.
                    ``(B) Written authorization.--Written authorization 
                under subparagraph (A) shall include a written estimate 
                of all costs associated with the conference, including 
                the cost of all food, beverages, audio-visual 
                equipment, honoraria for speakers, and entertainment.
                    ``(C) Report.--
                            ``(i) Department of justice.--The Deputy 
                        Attorney General shall submit to the applicable 
                        committees an annual report on all conference 
                        expenditures approved by the Attorney General 
                        under this paragraph.
                            ``(ii) Department of health and human 
                        services.--The Deputy Secretary of Health and 
                        Human Services shall submit to the applicable 
                        committees an annual report on all conference 
                        expenditures approved by the Secretary of 
                        Health and Human Services under this paragraph.
            ``(4) Annual certification.--Beginning in the first fiscal 
        year beginning after the date of enactment of this section, 
        each covered official shall submit to the applicable committees 
        an annual certification--
                    ``(A) indicating whether--
                            ``(i) all audits issued by the Office of 
                        the Inspector General of the applicable agency 
                        under paragraph (1) have been completed and 
                        reviewed by the appropriate Assistant Attorney 
                        General or Director, or the appropriate 
                        official of the Department of Health and Human 
                        Services, as applicable;
                            ``(ii) all mandatory exclusions required 
                        under paragraph (1)(C) have been issued; and
                            ``(iii) all reimbursements required under 
                        paragraph (1)(E) have been made; and
                    ``(B) that includes a list of any grant recipients 
                excluded under paragraph (1) from the previous year.
    ``(c) Preventing Duplicative Grants.--
            ``(1) In general.--Before a covered official awards a grant 
        to an applicant under this part, the covered official shall 
        compare potential grant awards with other grants awarded under 
        this part by the covered official to determine if duplicate 
        grant awards are awarded for the same purpose.
            ``(2) Report.--If a covered official awards duplicate 
        grants to the same applicant for the same purpose, the covered 
        official shall submit to the applicable committees a report 
        that includes--
                    ``(A) a list of all duplicate grants awarded, 
                including the total dollar amount of any duplicate 
                grants awarded; and
                    ``(B) the reason the covered official awarded the 
                duplicate grants.''.
    (b) Other Grants.--
            (1) Definitions.--In this subsection--
                    (A) the term ``applicable committees''--
                            (i) with respect to the Attorney General 
                        and any other official of the Department of 
                        Justice, means--
                                    (I) the Committee on the Judiciary 
                                of the Senate; and
                                    (II) the Committee on the Judiciary 
                                of the House of Representatives; and
                            (ii) with respect to the Secretary of 
                        Health and Human Services and any other 
                        official of the Department of Health and Human 
                        Services, means--
                                    (I) the Committee on Health, 
                                Education, Labor, and Pensions of the 
                                Senate; and
                                    (II) the Committee on Energy and 
                                Commerce of the House of 
                                Representatives;
                    (B) the term ``covered agency'' means--
                            (i) the Department of Justice; and
                            (ii) the Department of Health and Human 
                        Services; and
                    (C) the term ``covered official'' means--
                            (i) the Attorney General; and
                            (ii) the Secretary of Health and Human 
                        Services.
            (2) Accountability.--All grants awarded by a covered 
        official under section 201, 302, or 601 shall be subject to the 
        following accountability provisions:
                    (A) Audit requirement.--
                            (i) Definition.--In this subparagraph, the 
                        term ``unresolved audit finding'' means a 
                        finding in the final audit report of the 
                        Inspector General of a covered agency that the 
                        audited grantee has utilized grant funds for an 
                        unauthorized expenditure or otherwise 
                        unallowable cost that is not closed or resolved 
                        within 12 months after the date on which the 
                        final audit report is issued.
                            (ii) Audit.--Beginning in the first fiscal 
                        year beginning after the date of enactment of 
                        this Act, and in each fiscal year thereafter, 
                        the Inspector General of a covered agency shall 
                        conduct audits of recipients of grants awarded 
                        by the applicable covered official under 
                        section 201, 302, or 601 to prevent waste, 
                        fraud, and abuse of funds by grantees. The 
                        Inspector General shall determine the 
                        appropriate number of grantees to be audited 
                        each year.
                            (iii) Mandatory exclusion.--A recipient of 
                        grant funds under section 201, 302, or 601 that 
                        is found to have an unresolved audit finding 
                        shall not be eligible to receive grant funds 
                        under those sections during the first 2 fiscal 
                        years beginning after the end of the 12-month 
                        period described in clause (i).
                            (iv) Priority.--In awarding grants under 
                        section 201, 302, or 601, a covered official 
                        shall give priority to eligible applicants that 
                        did not have an unresolved audit finding during 
                        the 3 fiscal years before submitting an 
                        application for a grant under such section.
                            (v) Reimbursement.--If an entity is awarded 
                        grant funds under section 201, 302, or 601 
                        during the 2-fiscal-year period during which 
                        the entity is barred from receiving grants 
                        under clause (iii), the covered official that 
                        awarded the funds shall--
                                    (I) deposit an amount equal to the 
                                amount of the grant funds that were 
                                improperly awarded to the grantee into 
                                the General Fund of the Treasury; and
                                    (II) seek to recoup the costs of 
                                the repayment to the fund from the 
                                grant recipient that was erroneously 
                                awarded grant funds.
                    (B) Nonprofit organization requirements.--
                            (i) Definition.--For purposes of this 
                        subparagraph and the grant programs under 
                        sections 201, 302, and 601, the term 
                        ``nonprofit organization'' means an 
                        organization that is described in section 
                        501(c)(3) of the Internal Revenue Code of 1986 
                        and is exempt from taxation under section 
                        501(a) of such Code.
                            (ii) Prohibition.--A covered official may 
                        not award a grant under this section 201, 302, 
                        or 601 to a nonprofit organization that holds 
                        money in offshore accounts for the purpose of 
                        avoiding paying the tax described in section 
                        511(a) of the Internal Revenue Code of 1986.
                            (iii) Disclosure.--Each nonprofit 
                        organization that is awarded a grant under 
                        section 201, 302, or 601 and uses the 
                        procedures prescribed in regulations to create 
                        a rebuttable presumption of reasonableness for 
                        the compensation of its officers, directors, 
                        trustees, and key employees, shall disclose to 
                        the applicable covered official, in the 
                        application for the grant, the process for 
                        determining such compensation, including the 
                        independent persons involved in reviewing and 
                        approving such compensation, the comparability 
                        data used, and contemporaneous substantiation 
                        of the deliberation and decision. Upon request, 
                        a covered official shall make the information 
                        disclosed under this clause available for 
                        public inspection.
                    (C) Conference expenditures.--
                            (i) Limitation.--No amounts made available 
                        to a covered official under section 201, 302, 
                        or 601 may be used by the covered official, or 
                        by any individual or entity awarded 
                        discretionary funds through a cooperative 
                        agreement under those sections, to host or 
                        support any expenditure for conferences that 
                        uses more than $20,000 in funds made available 
                        by the covered official, unless the covered 
                        official provides prior written authorization 
                        that the funds may be expended to host the 
                        conference.
                            (ii) Written authorization.--Written 
                        authorization under clause (i) shall include a 
                        written estimate of all costs associated with 
                        the conference, including the cost of all food, 
                        beverages, audio-visual equipment, honoraria 
                        for speakers, and entertainment.
                            (iii) Report.--
                                    (I) Department of justice.--The 
                                Deputy Attorney General shall submit to 
                                the applicable committees an annual 
                                report on all conference expenditures 
                                approved by the Attorney General under 
                                this subparagraph.
                                    (II) Department of health and human 
                                services.--The Deputy Secretary of 
                                Health and Human Services shall submit 
                                to the applicable committees an annual 
                                report on all conference expenditures 
                                approved by the Secretary of Health and 
                                Human Services under this subparagraph.
                    (D) Annual certification.--Beginning in the first 
                fiscal year beginning after the date of enactment of 
                this Act, each covered official shall submit to the 
                applicable committees an annual certification--
                            (i) indicating whether--
                                    (I) all audits issued by the Office 
                                of the Inspector General of the 
                                applicable agency under subparagraph 
                                (A) have been completed and reviewed by 
                                the appropriate Assistant Attorney 
                                General or Director, or the appropriate 
                                official of the Department of Health 
                                and Human Services, as applicable;
                                    (II) all mandatory exclusions 
                                required under subparagraph (A)(iii) 
                                have been issued; and
                                    (III) all reimbursements required 
                                under subparagraph (A)(v) have been 
                                made; and
                            (ii) that includes a list of any grant 
                        recipients excluded under subparagraph (A) from 
                        the previous year.
            (3) Preventing duplicative grants.--
                    (A) In general.--Before a covered official awards a 
                grant to an applicant under section 201, 302, or 601, 
                the covered official shall compare potential grant 
                awards with other grants awarded under those sections 
                by the covered official to determine if duplicate grant 
                awards are awarded for the same purpose.
                    (B) Report.--If a covered official awards duplicate 
                grants to the same applicant for the same purpose, the 
                covered official shall submit to the to the applicable 
                committees a report that includes--
                            (i) a list of all duplicate grants awarded, 
                        including the total dollar amount of any 
                        duplicate grants awarded; and
                            (ii) the reason the covered official 
                        awarded the duplicate grants.
                                                       Calendar No. 369

114th CONGRESS

  2d Session

                                 S. 524

_______________________________________________________________________

                                 A BILL

   To authorize the Attorney General to award grants to address the 
    national epidemics of prescription opioid abuse and heroin use.

_______________________________________________________________________

                           February 22, 2016

                       Reported with an amendment
```